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A Role for Focal Adhesions and Extracellular Matrix in Traumatic Axonal Injury 
Abstract 
Traumatic Brain Injury (TBI) is linked to a diverse range of diffuse pathological damage for 
which there is a severe lack of therapeutic options.  A major limitation to drug development is the 
inability to identify causal mechanisms that link head trauma to the multitude of secondary injury 
cascades that underlie neuropathology.  To elucidate these relationships, it is important to consider how 
physical forces are transmitted through the brain across multiple spatial scales ranging from the whole 
head to the sub-cellular level.  In doing so, the mechanical behavior of the brain is typically characterized 
solely by its material properties and biological structure.  Alternatively, forces transmitted through 
distinct cellular and extracellular structures have been shown to influence physiological processes in 
multiple cell types through the transduction of mechanical forces into cellular chemical responses. As an 
essential component of various biological processes, these mechanotransduction events are regulated by 
mechanical cues directed through extracellular matrix (ECM) and cell adhesion molecules (CAM) to 
mechanosensitive intra-cellular structures such as focal adhesions (FAs).  Using a series of in vitro 
models, we have implicated FAs in the cellular mechanism of traumatic axonal injury by showing that 
forces directed through these structures potentiate injury levels and, moreover, that inhibition of FA-
mediated signaling pathways may be neuroprotective. In addition, we show that localizing trauma forces 
through specific brain ECM results in differential injury rates, further implicating mechanosensitive cell-
ECM linkages in the mechanism of TBI.  Therefore, we show that FAs play a major role in axonal injury 
at low strain magnitudes indicating that cellular mechanotransduction may be an important mechanism 
underlying the initiation of cell and sub-cellular injuries ultimately responsible for the diffuse 
pathological damage and clinical symptoms observed in diffuse axonal injury.  Furthermore, since these 
mechanisms may present the earliest events in the complex sequelae associated with TBI, they also 
represent potential therapeutic opportunities. 
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1 Mechanisms of Diffuse Damage Caused by Traumatic Brain Injury 
1.1 Introduction 
Traumatic Brain Injury (TBI) is caused by a mechanical insult to the head and is estimated to 
affect 1.7 million people annually in the United States [92] and 235 per 100,000 people annually 
in Europe [274].  TBI is categorized as mild, moderate, or severe based on clinical symptoms 
often in combination with imaging and post mortem histology.  Pathological lesions consisting of 
contusion, hemorrhage, and edema are clinical indicators of head injuries.  As such, traumatic 
cell death in regions directly adjacent to sites of trauma is often viewed as the primary 
neurological damage [3,105,116,238,308].  However, it is now understood that additional forms 
of neuropathology contribute significantly to the ensuing morbidity associated with TBI.   
Broadly described as diffuse TBI, a complex array of microscale pathologies including 
diffuse axonal injury (DAI), microvascular damage, and diffuse neuronal injury can develop 
throughout the brain parenchyma following trauma.  Even though clinical symptoms may 
improve, the microscale damage can persist and potentially contributes to an increased likelihood 
of future neurodegenerative disease [102,189,114].  Although the risk associated with diffuse 
damage has clearly emerged, a comprehensive understanding of the mechanical and biological 
processes that initiate this damage remains elusive.   
Difficulties in identifying the events that initiate diffuse pathologies are likely due in part to 
the complexity of characterizing forces distributed through structures ranging in size from the 
whole brain down to subcellular levels [60].  Understanding the biomechanical events that 
initiate brain injuries has typically relied on determining how neural tissue responds to rapidly 
applied loads through both mathematical modeling and experimental techniques [164,60,52].  In 
order to understand disease pathogenesis, there has been a tendency to focus on forces that 
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disrupt the integrity of the networked architecture of the brain [275,152].  However, establishing 
a causal link between a mechanical insult and the ensuing diffuse pathology observed in TBI has 
been met with limited success. 
In this dissertation, we begin by introducing the known diffuse neuropathological damage 
associated with TBI and the multi-scale biomechanics that may explain patterns of cell-level 
injury in the brain.  We propose that to improve the mechanistic understanding of diffuse brain 
damage, it may be necessary to consider how mechanical forces below the threshold for 
mechanical failure influence cellular physiological processes.  Specifically, we hypothesize that 
injury forces directed through extracellular matrix molecules activate cellular 
mechanotransduction mechanisms that cause axonal injury.  The importance of cellular 
mechanotransduction, or the ability of cells to convert mechanical forces into biological signals, 
has been widely established in many organs, tissues, and cells across multiple species 
[292,289,291].  Cell-cell and cell-matrix interactions have been shown to influence both 
physiological and pathophysiological processes [131,139], suggesting that they play an important 
role in brain injury and remodeling after TBI.  Herein, we focus on understanding whether the 
brain ECM serves as a conduit to direct forces associated with mechanical trauma through 
mechanosensitive cellular structures that affect axonal injury.   
1.2 Biomechanics and Neuropathology of Traumatic Brain Injury 
1.2.1 Trauma Induced Local and Distributed Loading Within the Brain  
Many studies have explored the role of sudden impact, acceleration, and blast force in 
brain injury [221,220,17] (Fig. 1-1).  Localized forces are typically associated with impact 
injuries where the brain deforms against the skull, while distributed loading is typically attributed 
to both inertial forces due to rapid head acceleration [220] as well as pressure transients due to 
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explosive blast waves [17].  Although these loading patterns are not mutually exclusive, we will 
focus on the current limitations in understanding the effects of diffuse loading patterns and the 
complexity of understanding the cellular damage and injury mechanisms associated with them.  
1.2.2 Assessing and Diagnosing Anatomical Brain Injury 
  Diagnosis of TBI typically relies on a neurological assessment followed by imaging to 
detect pathology.  Classes of TBI pathology, termed focal and diffuse, have been attributed to 
local and distributed loading in the brain.  Povlishock and Katz suggested a distinct classification 
between focal and diffuse injuries predicated upon both clinical and basic science perspectives, 
with the acknowledgement of some overlap in pathobiology and clinical outcome [235]. They 
classified a typical focal injury as consisting of contusion and hemorrhage located near the site of 
impact and a diffuse injury as consisting of diffuse axonal injury (DAI) and petechial white 
matter hemorrhage located at multiple sites throughout the brain.   
While pathological lesions consisting of contusion and hematoma formation associated 
with focal injures are readily distinguishable by CT and traditional MRI scans, DAI and other 
 
Figure 1-1: Mechanical Loading of the Brain Due to Trauma. 
A mechanical insult to the head resulting from impact, acceleration, or blast forces can generate both 
localized and distributed forces throughout the brain.  Localized forces typically occur due to impact 
of the brain against the skull.  Distributed forces can be caused by inertial effects during rapid 
acceleration or by increased pressure transients caused by explosive blast. 
 
 
 
 
 
4 
 
subtle hemorrhages are not.  For example, abnormalities were detected by CT scan in only 5-
30% of patients exhibiting clinical symptoms consistent with  mild TBI (mTBI) [35], and the 
extent of pathology detected by CT scan and MRI did not correlate with the clinical outcomes 
[167].  Therefore, identifying diffuse pathology following head injury has historically relied on 
postmortem histological analysis in which DAI is detected by the presence of punctate, swollen 
axons [269].  The inability to measure the extent of diffuse pathology demonstrates a deficiency 
in diagnostic methods that may contribute to the debate about the etiology of TBI. 
A major breakthrough occurred in 2002 when Arfanakis et al. showed that Diffusion 
Tensor Imaging (DTI), a form of MRI, could detect abnormalities not found on CT scans in 
patients diagnosed with TBI within 24 hours of trauma [11].  DTI abnormalities were measured 
as regional reductions in diffusion anisotropy, which were later shown to correlate with regions 
of axonal damage from histological analysis [180].  Subsequent studies further correlated 
reductions in diffusion anisotropy with neuropsychological dysfunction in longitudinal studies 
[20] while also showing that DTI abnormalities can be used to predict cognitive outcome [117].  
The incorporation of DTI as a diagnostic technique has improved the ability to identify diffuse 
brain damage and may contribute to an understanding of how diffuse pathology may contribute 
to TBI related morbidity.      
Recent reports have shown that diffuse damage can occur even after mild insults with no 
previously identifiable neuropathology [190,265,218], supporting the notion that diffuse damage 
may contribute more greatly to morbidity than previously understood.  Concussion and repetitive 
sub-concussive impacts are now linked to progressive neurodegeneration classified as Chronic 
Traumatic Encephalopathy (CTE) [190]. This disease was first reported in boxing as dementia 
pugilistica where it was characterized clinically by declining mental capacity, lack of 
5 
 
coordination, and behavioral problems [63].  McKee et al. showed that professional athletes who 
suffered repetitive mTBI developed diffuse, microscale injury patterns characterized by post-
mortem identification of neurofibrillary and glial tangles, hyperphosphorylated tau, axonal 
degeneration, and immunoreactive microglia [189].  Moreover, blast combat casualties from the 
wars in Afghanistan and Iraq exhibited similar tissue damage [114] as well as additional 
pathology such as cerebral vasospasm [12] and traumatic axonal injury [181].  The diffuse 
neuropathological changes associated with CTE and explosive blast, some of which are distinct 
from those previously attributed to TBI, suggest that the extent of diffuse brain damage, 
especially following mTBI, may be greater than previously understood.   
While traumatic cell death attributed to focal injuries was for many years viewed as the 
primary contributor to morbidity following TBI, it is now understood that pathophysiological 
conditions may ensue even without widespread cell death [91].  For example, an acute phase of 
neuroexcitation was shown to occur in the brain immediately following impact.  This event has 
been linked to the indiscriminant release of neurotransmitters, such as glutamate, that activate 
excitatory neurons [314,6].  Diffuse patterns of metabolic change throughout the brain of live 
human patients have been detected following trauma using Positron Emission Tomography 
(PET) [22].  These abnormal activity patterns have been shown to initiate immediately and 
persist up to weeks following the initial insult.  Furthermore, these changes were identified in 
patients diagnosed with mTBI based upon neurological assessment, in which neither focal 
pathology nor, in some cases, diffuse pathology was detected.  Glutamate release combined with 
a loss of ionic homeostasis may manifest in mitochondrial dysfunction [112] and lead to general 
cellular dysfunction.  A combination of acute neuroexcitation and potential vascular damage is 
believed to lead to a cellular energy crisis.  Furthermore, progressive degeneration linked to this 
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energy crisis may lead to deafferentiation, or a loss of synaptic terminals [86], affecting 
regulation of neuronal activity patterns that are crucial to brain function.  Recently, patients with 
mTBI were shown to exhibit decreased connectivity between brain regions, as measured by 
magnetoencephalography [322].  Therefore, a diverse range of pathophysiological events may 
occur following TBI.  The diffuse patterns of pathology and functional impairment in patients 
lacking focal injuries supports the notion that diffuse damage may contribute significantly to the 
morbidity associated with TBI.   
While multiple forms of diffuse pathology have been identified and the extent of 
associated pathophysiological change is still emerging, many questions remain regarding the 
development of diffuse tissue damage.  In addition to questions surrounding the initiating events, 
a difficult problem remains in understanding the spatiotemporal distribution of diffuse pathology.    
1.2.3 Regional Susceptibility to Diffuse Pathology 
Identification of diffuse damage throughout the brain has revealed non-uniform 
distributions of injury suggesting that certain tissue and cellular structures may be more 
vulnerable than others.  Blumbergs et al. compared the extent of DAI occurring in multiple brain 
regions by analyzing histological slices from patients diagnosed with either mild or severe TBI 
[34].  Following mTBI, no evidence of DAI was detected in the cerebellum, one half of the 
patients exhibited injury in the brainstem, and all patients exhibited injury in the cerebral 
hemispheres.  Following severe TBI, patients exhibited evidence of DAI in all examined regions.  
White matter within the cerebral cortex and large axonal tracts within the cerebral hemispheres, 
such as the corpus callosum and fornices, were especially susceptible to injury.  These 
vulnerabilities were supported by findings in patients in which MRI was used to detect a greater 
number of lesions located in the cerebral hemispheres compared to the brainstem, which also 
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correlated with injury severity [146].  A preferential decrease in diffusion anisotropy has been 
measured in structures such as the corpus callosum, internal capsule, and the centrum semiovale 
[137], confirming the susceptibility of large axonal bundles to damage.  DAI lesions have also 
been shown to localize to the interface of cerebral white and gray matter [258].  Therefore, 
diffuse damage appears to differentially affect tissue regions and structures within the brain. 
Although diffuse pathology appears primarily in certain brain regions and tissue 
structures, heterogeneity at the cellular level also exists within these damaged regions.  For 
example, injured regions are typically distributed in a multi-focal pattern [259].  Furthermore,  
injured axons are typically dispersed amongst neighboring uninjured axons within these focal 
regions [34]. Heterogeneity in axonal vulnerability is also suggested by reports indicating 
differential injury responses in myelinated versus small caliber, non-myelinated axons [241].  
Within myelinated axons, DAI has been shown to occur preferentially at the Nodes of Ranvier 
[240], which are the periodic regions of exposed axon between regions of myelination.    
Additional heterogeneity in injury distribution is observed in relation to the 
microvasculature.  Evidence of diffuse damage in the vasculature has been suggested by micro-
hemorrhage of small vessels, which often occurs diffusely within the white matter similar to that 
of DAI [34].  Furthermore, tau-immunoreactive neurofibrillary and astrocytic tangles associated 
with CTE have been shown to exhibit perivascular localization [189] suggesting a role for the 
vasculature in the injury process.   
Biomechanical studies provide some explanation for diffuse injury distributions 
[220,130], however, the growing diversity of diffuse pathology combined with the inability to 
explain cellular and sub-cellular injury patterns highlights the difficulties in understanding how 
this damage occurs.  Purely mechanical explanations provide some insight into injury initiating 
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mechanisms.  For example, Ommaya and Gennerelli posited that head rotation results in an 
injury distribution consistent with the degree of inertial forces generated by centripetal 
acceleration [219].  However, explaining the subsequent distribution of diffuse tissue, cellular, 
and sub-cellular damage due to head trauma is complicated by several orders of spatial 
magnitude that separate these anatomies.  Therefore, to understand the diversity of injury that 
comprises diffuse damage, it may be necessary to consider the multi-scale mechanics that 
characterizes brain trauma.   
1.3 Multiscale Biomechanics and Mechanisms of Diffuse Traumatic Brain Injury 
1.3.1 Multiscale Structural Organization and Mechanical Properties of the Brain  
Biomechanics of TBI are complicated by the brain’s diversity in structure and range of 
material properties.  Although the brain is a relatively soft tissue, it is encased by multiple layers 
of tissue and fluid that provide protection from mechanical forces.  These protective layers 
include the skin (~1.0 MPa), the skull (~8.0 GPa), the dura matter (31.5 MPa), the pia matter 
(11.5 MPa), and the cerebral spinal fluid [318].  Together, these multiple layers provide a 
relatively rigid structure that protects the much softer underlying brain tissue from normal 
environmental factors, such as mechanical trauma. The underlying brain tissue is characterized 
by large brain regions such as the cerebral hemispheres, the cerebellum, and the brain stem (Fig. 
1-2A), which are defined by anatomical features and functional properties [39,150].  Early 
studies on human brain tissue reported shear stiffness between 0.6 and 1.1 kPa [89], indicating 
that the brain is relatively soft and susceptible to deformation compared to other biological 
tissues.  Subsequent studies highlighted the variation in mechanical properties due to age, region, 
and sample preparation [236], reporting values between 0.7-33 kPa [276].  Brain tissue also 
exhibits viscoelastic behavior, with loss modulus ranging between 2.8-81.4 kPa [256], indicating 
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the greater the rate of an applied load the greater the apparent stiffness.  The variation in material 
properties of brain tissue is clearly indicated by elasticity maps of rodent brains showing regional 
variations in shear stiffness ranging between 2-25 kPa [182,286].  Therefore, the brain is 
considered a heterogeneous material.   
Differences in material properties between brain regions are attributed to differences in 
cell population demographics, network architectures, and other micro-architectural attributes that 
facilitate functional uniqueness.  The adult human brain consists of a diverse cellular population 
of approximately 100 billion neurons and at least as many non-neuronal cells [14]. Neuronal, 
glial, and vascular cells are the primary constituents of the brain parenchyma and together form 
intricate cellular and multicellular structures (Fig. 1-2B).  Neurons are polarized cells that 
transmit electrical signals through small diameter processes (axons and dendrites) that extend 
away from their cell body (soma) to neighboring cells [39,150].  While the typical neuronal cell 
body is 10 - 50 μm in diameter, neuronal processes extend up to 500 μm (dendrites) or several 
centimeters to a meter (axons) away while remaining only 0.2-20 μm in diameter [150,4,239].   
In addition to neuronal processes, other cellular constituents also exhibit polarized 
morphologies that form complex multi-cellular structures. For example, oligodendrocytes wrap 
multiple layers of cellular processes around axons at consistently spaced intervals to form 
myelination.  It is this precise wrapping that forms periodic regions of exposed axon called 
Nodes of Ranvier that are important for electrical conduction.  Astrocyte processes interact with 
axons and dendrites to form synapses that are critical for transmitting signals between neurons.  
The cerebral vasculature forms prominent structures within the brain with vessels existing in a 
large range of diameters:1-3 mm for large arteries and veins [88], 10-60 μm for small arterioles 
and venules, and 4-8 μm for capillaries [321].  While larger vessels near the surface of the brain 
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are sparse, smaller vessels within the parenchyma have been reported at high densities ranging 
from 25 per mm2 in the corpus callosum to 150 per mm2 in the hippocampus [51].  Together, 
these multicellular constituents form complex micro-structures throughout the brain.   
In addition to structural complexity, neural cells exhibit differences in mechanical 
properties.  Heterogeneity in mechanical properties is important because it indicates that 
 
Figure 1-2: Structural Organization of the Brain. 
Understanding the occurrence of diffuse pathology at the cellular level is complicated by the intricate 
cell and tissue structures that span ~4 orders of magnitude in spatial scale to form the human brain. (A) 
Large brain regions such as the cerebral hemispheres (comprised of four lobes), the cerebellum, and the 
brain stem are well defined by anatomical features and functional properties. (B) Within each tissue 
structure, there is an underlying multicellular composition comprised of neurons, neuroglia, and vascular 
cells.  Many of these cells are highly polarized and together form intricate multi-cellular structures.  
Differences in material properties between brain regions are attributed to differences in cell population 
demographics, network architectures, and other micro-architectural attributes that facilitate functional 
uniqueness.     
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different regions or cell types may deform differently when experiencing the same load.   For 
example, astrocytes may deform to a greater extent than neurons since elasticity measurements 
have shown neuronal somas to vary between 480 Pa and 970 Pa [23,74] and astrocyte somas to 
vary between 300 Pa and 520 Pa [177].  A difference may also exist between sub-cellular 
regions, as neuronal soma stiffness was reported to be ~ 500 Pa [25,177] while axons were 
reported to be ~12 kPa [23,74].  Evidence of delayed elasticity has been observed in some axons 
following rapid stretch, in which a return to their initial length occurs over timescales much 
larger than the initial stretch [275,260].  Therefore, traditional mechanical metrics such as 
elasticity may not fully capture the behavior of these biological structures.   
Heterogeneity in mechanical properties is also important because of the potential for 
shear forces to occur at the interface between regions with different shear stiffness.  These 
interfaces exist between prominent structures such as cerebral white and gray matter [258], 
which were measured in humans to have shear stiffnesses of 13.6 kPa and 5.22 kPa, respectively 
[160].  Additionally, the stiffness of human arteries was reported to be ~20 MPa and veins to be 
~3MPa [200], 2-4 orders of magnitude larger than bulk brain tissue.  Although the largest 
arteries and veins course superficially in the brain, smaller arterioles, venules, and capillaries 
permeate the brain parenchyma and account for ~2.5% of the total volume [214], providing for 
regional material heterogeneity.  
The complexity of the cellular and multi-cellular structures within the brain can likely 
explain the heterogeneous mechanical properties observed within the tissue.  The structural and 
mechanical properties at the cellular and sub-cellular level must therefore be considered in 
mechanical analyses to properly understand the brain’s vulnerability to trauma.   
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1.3.2 Linking Biomechanics to Mechanisms of Diffuse Traumatic Brain Injury 
Mathematical modeling and experimental techniques are providing insight as to how 
forces applied to the brain are transmitted to the cellular level.  By including cellular anisotropy, 
multi-scale models have recapitulated the effect of cellular structures, such as the 
microvasculature and axonal bundle orientation, on localized cellular strain and have begun to 
incorporate these effects over the spatial scales of TBI [55,306,60].   These models have 
suggested that vessels can create microscale heterogeneities that increase localized stress or 
strain generation near the vessel, potentially explaining the susceptibility of these structures to 
injury [61]. For example, microscale inclusions were predicted to increase localized cellular 
strain levels by 60% compared to the gross tissue level.  Furthermore, the same modeling effort 
suggested that vessels may force abrupt changes in axonal orientation that can affect localized 
strain distribution along the axon.  Mathematical predictions of microscale variations in strain 
have been verified by high-speed optical measurements of tissue deformation that indicate 
inhomogeneity in strain fields in local regions containing both white and grey matter  [166]. 
Therefore, gross tissue deformation may not completely describe the distribution of forces 
exerted on the underlying cellular structures or the variability in cellular injury within a region of 
the brain.   
Although forces exerted on the brain initiate biological processes associated with diffuse 
pathology, the sequence of events between initial injury and subsequent pathology is poorly 
understood.  Transient membrane tearing, termed mechanoporation has been suggested as a 
possible mechanism in axonal injury [152,106].  Mechanoporation is believed to occur in 
response to a rapid increase in axonal strain, which has been shown using in vitro stretch models 
of axonal injury.  In these experiments, 30% uni-axial strain applied at a rate of 10s-1 resulted in 
brief tearing of the membrane that is observed through the cellular uptake of a membrane 
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impermeable marker [104].  It is proposed that transient membrane tearing causes a loss in 
cellular homeostasis that initiates a cascade of secondary events that ultimately result in DAI.   
The presence of punctate swollen axons, the hallmark morphology associated with DAI, 
has been linked to a progressive series of cellular pathologies believed to result from 
mechanoporation.  Previous studies have suggested that cytoskeletal abnormalities occur due to 
impaired axonal transport, causing an accumulation of vesicles and organelles leading to axonal 
swelling [2,59,108,233,234].  This disruption is thought to result from the action of cysteine 
proteases, such as calpains and caspases that degrade the cytoskeleton  [47]. The involvement of 
protease activation in cytoskeleton disruption is supported by improved injury outcomes in rats 
that were administered protease inhibitors prior to or following experimental brain injury 
[45,245,231,246,161].  Pathological activation of proteases has been linked to an influx of ions, 
such as Ca2+ and  Na+,  that occurs due to mechanoporation [152,103,153]. As such, one 
therapeutic candidate, Poloxamer 188, has shown the potential to treat DAI by promoting 
membrane resealing.  Although Poloxamer 188 has exhibited neuroprotective effects following 
TBI in animal models, it has yet to be tested in humans [15,254].  Therefore, no therapeutic 
treatment options currently exist that effectively target a specific injury mechanism of DAI.    
1.3.3 Current Limitations in the Understanding of Diffuse Traumatic Brain Injury 
Mechanisms  
 While membrane poration has been linked to much of the secondary injury cascade 
associated with DAI using experimental models, its role as the sole injury mechanism is not 
without controversy.  Evidence of cytoskeleton breakdown, as indicated by calpain-mediated 
proteolysis [90,305], as well as impaired axonal transport [267], have been reported to occur 
without evidence of membrane poration, challenging the membrane poration hypothesis.  
Additional injury markers such as neurofilament compaction have also been shown to occur in 
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different cell populations than impaired axonal transport implicating the existence of multiple 
injury mechanisms [76].  Although not investigated as extensively as mechanoporation, 
additional injury mechanisms, including traumatic mechanical failure of microtubules [275] and 
impaired sodium channel function [138] can be linked to the secondary injury cascades 
associated with DAI.  
 Therefore, additional mechanisms likely exist by which neural cells respond to 
mechanical forces associated with TBI resulting in subsequent injury.  While mechanical failure 
of biological structures such as the cell membrane or cytoskeleton is likely to occur when 
sufficient forces are applied, the potential for physical forces below mechanical failure 
thresholds to influence physiological processes provides additional mechanisms to explore.   
1.4 Mechanobiology and the Cellular Microenvironment of the Brain  
1.4.1 Mechanisms of Conversion of Mechanical Signals to Biochemical Signals 
 Cellular mechanotransduction, or the ability of cells to convert physical forces into 
biological signals, is a widely established phenomenon that has been linked to the regulation of 
diverse cellular physiological processes [131] including morphogenesis, growth, and survival 
[110,123].  Mechanotransduction pathways are influenced by interactions between intracellular 
structures, such as the cytoskeleton, and extracellular structures, such as the ECM or neighboring 
cells, through CAMs in the cell membrane.  Mechanical coupling of the intracellular and 
extracellular space allows cells to ‘sense’ their local mechanical environment through physical 
interactions directed through these structures [144], and their mechanosensitive properties have 
been demonstrated in many cell types [122].   
 Several mechanisms exist by which exogenous forces are converted by sub-cellular 
mechanosensitive components into biochemical signals that influence cellular processes.  Both 
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properties of the cellular microenvironment, such as ECM stiffness [176,313,77], and dynamic 
conditions, such as a change in cellular force distribution [185,187,316], can affect development, 
differentiation, disease, and regeneration by influencing gene expression and biochemical 
signaling pathways [165,132,298].  Redistribution of forces within a cell can be initiated by 
intracellular events, such as alterations in the cytoskeleton due to remodeling of microtubules 
[18], and also by extracellular events, such as an exogenous force directed through CAMs [292].  
The conversion of force to biological signals is accomplished by changes in interactions and 
properties of proteins, often localized to intracellular structures such as the integrin associated 
focal adhesion complex, that regulate the activation of biochemical signaling pathways 
[168,185].  For example, changes in the relative force balance between the intracellular and 
extracellular space have been linked to acute cytoskeleton remodeling [282] through the 
activation of Rho signaling pathways [319].  The mechanochemical control mechanism is 
believed to occur through force induced enzymatic activation of protein kinases.  Interestingly, a 
single mechanical perturbation has been shown to activate Src kinase in both endothelial and 
smooth muscle cells [209,253], suggesting that an acute insult may be sufficient to influence 
biological signaling pathways.  Moreover, this activation can occur at locations distant to the 
stimulus site and over time scales that cannot be accomplished by diffusion or active transport, 
suggesting mechanical propagation through the cytoskeleton.  Force transmission through the 
cytoskeleton has been previously postulated to explain how mechanotransduction may alter 
signaling pathways in the nucleus that affect gene expression [298].  While extensive literature 
has focused on mechanotransduction in multiple cell types, relatively few have focused on it 
within the developed brain.  Nonetheless, the ubiquitous nature of these sub-cellular components 
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and signaling pathways suggest a potential for similar phenomena to occur within the developed 
brain.   
1.4.2 Mechanobiology of the Developed Brain  
 Although the brain is typically viewed as a mechanically isolated organ, mechanical 
interactions at the cellular and sub-cellular level are critical components of normal biological 
function.  Both the existence of endogenous forces as well as their influence on cellular function 
within the developed brain have been reported [281].  Specifically, mechanical interactions 
between sub-cellular structures such as the cell membrane, CSK, ECM, CAMs, and ion channels 
have been shown to influence diverse neural functions including ion channel activity [13], 
synaptic vesicle clustering [257], neurotransmitter release [57], and axonal growth cone 
dynamics [261].  Signaling pathways associated with mechanotransduction have also been linked 
to important neuronal functions.  For example, integrin binding forms a mechanical linkage at 
the synapse, but subsequent activation of integrin mediated signaling pathways is a critical step 
in the formation and regulation of synapse morphology and maturation [24].  Moreover, RhoA 
activation has been shown to influence synaptic plasticity [311] potentially by affecting the 
structural stability of dendritic spines through cytoskeleton remodeling.  Integrin mediated 
RhoA-Rho Associated Kinase (ROCK) signaling also affects the potential for remyelination in 
damaged white matter [215], indicating the broad influence of these pathways in neural function.  
Although a comprehensive understanding is far from complete, the potential for physical forces 
to influence cellular function in the developed brain via cellular mechanotransduction is clearly 
evident.   
The cytoskeleton, CAMs, and ECM are important sub-cellular structures that contribute 
to the mechanical integrity of the cell.  The cytoskeleton consists of multiple filamentous 
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polymers including actin, microtubules, and neurofilaments that form an interconnected network 
with extracellular structures, such as the ECM (cell-ECM) or neighboring cells (cell-cell), 
through CAMs located in the cell membrane (Fig. 1-3) [144].  Actin filaments are 5-9 nm in 
diameter and, with cross-linking proteins, form load bearing structures within the cell 
[94,163,48].  Microtubules are ~25 nm in diameter and form rigid structures with stiffness 
measurements of ~100 MPa that can bear compressive loads [94,36,156].  Intermediate filaments 
are ~10 nm in diameter and have shown the ability to resist tensile forces by stretching up to 3.5 
fold [158,127].  Therefore, the cytoskeleton consists of biologically active filamentous structures 
that can provide mechanical integrity to the cell.    
Cell adhesion molecules, consisting of members of the integrin, cadherin, 
immunoglobulin, selectin, and proteoglycan superfamilies, are integral membrane proteins that 
provide mechanical continuity across the cell [120,198,290].  CAMs exhibit binding specificity 
to both intracellular and extracellular components, some of which are indicated in Table 1.  For 
example, tenascin binds integrins but not L1 IgCAMs [198,172], and CSPGs bind L1 IgCAMs 
but not integrins [183,290].  Furthermore, intracellular components, such as the focal adhesion 
complex, bind to integrins but not to cadherins [73,121].  This selective binding provides the 
ability to regulate mechanical coupling between the cell and its local microenvironment by 
influencing the organization of structural elements within the cell in response to both 
intracellular and extracellular cues.  
18 
 
 
 
 
Figure 1-3: Protein networks maintain connectivity and structural integrity of neural networks. 
Within all cell types, there are sub-cellular components that dictate cellular architecture by providing mechanical 
structure.  Such structure is formed by interconnected networks of proteins in both the intracellular and 
extracellular space.  Intracellular structures include cytoskeleton components such as actin, microtubules, 
neurofilaments, and crosslinking proteins (CP).  Extracellular structures include extracellular matrix proteins as 
well as neighboring cells.  These structures are connected through transmembrane receptors called cell adhesion 
molecules that include IgCAM (Ig), Selectin, Cadherin, Integrin, and other glycoproteins (GP) and 
proteoglycans (PG).  The resulting networks bear loads and distribute forces throughout the cell and across the 
cell membrane to the extracellular space and neighboring cells.   
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Table 1: Cell Adhesion Molecules and Binding Partners Expressed in the CNS 
 
Receptor 
Family 
Sub-Types 
Expressed 
in the CNS 
Intracellular 
Cytoskeleton 
Binding 
Extracellular 
Binding 
Associated Signaling 
Pathways 
References 
Integrin α(1,5,6,v) 
β(1,3) 
FAC  Actin 
α –actinin  
Actin 
 
ECM proteins 
(Laminin, 
Tenascin 
Reelin) CAM 
(Ig, Cadherin 
 
Rho-family GTPases 
PTK, PTP  
[73,175,133,148,
134] 
 
Cadherin N-Cadherin 
E-Cadherin 
Catenin  
Actin 
Desmoplakin  
IF 
Cadherin 
Integrin 
ECM 
(Reelin) 
 
Rho-family GTPases 
PTK 
Wnt signaling 
Src-family kinase 
[121{Nelson, 
2004 
#385,303,10,148,
212,155,21] 
 
[212,303,10,148,
155,21,118,119] 
IgCAM L1, NCAM Ankyrinspect
rin  Actin 
Ezrin  Actin 
IgCAM, 
Integrin, 
HSPG, CSPG 
PTK, PTP, MAPK 
Src-family kinase 
[119,68{Juliano, 
2002 
#84,148,223,155,
21] 
Selectin  α –actinin  
Actin 
 
Selectin 
PSGL-1 
MAPK, c-Src [148] 
Additional 
Glycoproteins 
and 
Proteoglycans 
CD44 
Neurexin 
Neuroligin 
ERM  Actin 
Ankyrin  
Actin 
 
HA, laminin,  
Neuroligin, 
Neurexin 
PTK (p195HER2, c-
src) 
Rho-family GTPases 
[285{Goodison, 
1999 
#456,280,115,21] 
HA: Hyaluronan, CSPG: Chondroitin Sulfate Proteoglycan, HSPG: Heparin Sulfate Proteoglycan, FAC: Focal Adhesion 
Complex, IF: Intermediate Filament, PTK: Protein Tyrosine Kinase, PTP: Protein Tyrosine Phosphatase, MAPK: Mitogen 
Activated Protein Kinase 
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1.5 Conclusion 
Given the critical importance of sub-cellular structures such as ECM and cell adhesion 
molecules in cell mechanics, we sought to determine their potential involvement in TBI.  
Specifically, we sought to determine if pathological cellular mechanotransduction may provide a 
mechanism by which axons are injured during diffuse TBI.  To do so, we utilized multiple in 
vitro models of DAI allowing the greatest level of control over the cellular structures necessary 
to address the following specific aims: 
1. Determine if focal adhesions transmit forces in such a way as to potentiate axonal injury 
as observed in Traumatic Brain Injury 
2. Determine if localizing injury forces through different ECM affects axonal injury levels 
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2 Focal Adhesion Density Affects Levels of Strain Induced Axonal Injury 
2.1 Introduction 
Over the past decade, investigators have attempted to establish the pathophysiological 
mechanisms by which non-penetrating injuries induce diffuse damage in the brain.  A primary 
motivator for the increased attention to non-penetrating injuries arose from the increased 
incidence of Blast-induced mild Traumatic Brain Injury (mTBI).  Blast mTBI is the most 
frequent wound of the conflicts in Afghanistan  and Iraq [29], with approximately 60% of total 
combat casualties associated with blast events generated by improvised explosive devices.  
Furthermore, recent studies suggest that nearly 16% of US combatants have been diagnosed with 
mTBI [129].  Although how blast energy is transmitted to the brain is not well understood, in 
vivo studies and clinical reports have shown that exposure to blast can cause mTBI [84,129,53].  
Interestingly, the neuronal injury observed in these studies  resembles DAI, a common pathology 
observed following mTBI in vivo [107].  DTI studies have identified structural alteration in white 
matter tracts in military personnel who previously suffered Blast-induced mTBI [263], and 
experimental mouse models have linked these structural alterations to DAI [179].  However, the 
mechanisms that initiate this pathophysiological response are unclear.   
In vitro models of TBI may not fully recapitulate the complexity of the brain structure or 
mechanical trauma, but they provide unique insight into its cellular pathology by allowing the 
manipulation of specific biological components.  Previous models of mTBI have proposed that a 
strain magnitude and rate dependent disruption in ion homeostasis initiates a sequence of 
secondary events ultimately leading to neuronal death.  However, evidence of membrane 
poration is not observed in all injured neurons [153,90], and excitotoxicity due to loss of ion 
channel homeostasis [262] cannot account for observations of axonal retraction.  
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We hypothesized that cellular mechanotransduction events at the focal adhesion initiate 
secondary injury cascades that cause axonal injury. Focal adhesions are clusters of proteins 
containing transmembrane integrin receptors that couple the cytoskeleton in the intracellular 
space to the ECM network in the extracellular space, providing mechanical continuity across the 
membrane [296]. Mechanical forces propagating through these coupled networks can activate 
signal transduction pathways, alter ion channel currents, and initiate pathological cascades 
[140,194]. In the brain, roles for integrin signaling have been studied extensively in development 
and memory potentiation [54,152,198,247,270,300], however, there are no reports on the role of 
integrin signaling in mTBI.  
 To test our hypothesis, we built a high velocity tissue stretcher to deliver an abrupt 
mechanical perturbation to cultured neonatal rat cortical neurons exhibiting varying amounts of 
ECM adhesion coupling. These experiments demonstrated that neuronal injury is a function of 
focal adhesion size and density, with greater FA presence corresponding to increased injury 
susceptibility. Membrane poration was only observed at extreme strains in a subset of 
experiments, whereas at lower strains, neurite focal swelling was observed without membrane 
poration. The injury was not mitigated with the use of a calpain inhibitor, suggesting a calpain-
independent injury mechanism. Treatment with a Rho-kinase inhibiter decreased neuronal injury, 
suggesting a role for mechanochemical signaling events in neuronal injury.  
 
2.2 Results 
2.2.1 High Speed Stretchers Induced Strain-Dependent Injury 
The spatio-temporal profile of the mechanical perturbation, such as a blast wave, in the brain 
during mTBI is likely variable and, given the timescale of blast wave propagation, quite rapid.  
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In order to mimic this sudden mechanical stimulus, we designed and built a high speed stretcher 
(HSS) system to  deliver an abrupt strain to a population of neurons cultured on a flexible silicon 
elastomer substrate coated with PLL (Fig. 2-1A), similar to previous in vitro stretch models [85]. 
We seeded primary neonatal rat cortical neurons on stretchable membranes five days before 
experiments to allow dendritic and axonal extension. During experiments, the substrates 
underwent an abrupt, uniaxial stretch (at 1% per ms) to generate a strain field of defined 
magnitude (Fig. 2-2). Neuronal injury was defined as the appearance of focal swellings along 
neurites, neurite retraction, or abrupt mechanical failure of the neurite (Fig. 2-1B), similar to 
injury morphologies reported in previous in vitro fluid shear models of injury [153] and similar 
to swellings seen in DAI in vivo [232]. We found that neuronal response to stretch was 
heterogeneous and dependent upon strain magnitude (Fig. 2-1C), similar to what has been 
reported in vivo [90].  Few neurons were lost, defined as abrupt failure of all attachment to the 
substrate, due to the stretch at strain magnitudes less than 10% and a small increase in loss was 
observed at 25% strain.  At 10 minutes following stretch, a significant increase in focal swelling 
was observed for strain magnitudes greater than 5%.   For all subsequent studies, we focused on 
strain magnitudes of 0-10%, as this range captured the threshold of inducing neuronal injury. 
Also, in this strain range only a small percentage of neurons exhibited signs of mechanoporation, 
as indicated by the uptake of membrane impermeable dye from the extracellular solution (Fig. 2-
1D), or apoptosis, as indicated by TUNEL staining (Fig. 2-3).  Thus, we identified a strain 
dependent injury response in our neuronal populations that is not explained by membrane 
poration. 
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Figure 2-1: High speed stretch model of neuronal cultures indicates a strain dependent injury 
response identified by focal swelling of the neurites without porating the membrane. 
(A) Neurons were cultured on elastomer membranes that were quickly stretched, transferring injurious 
forces to neurons.  (B) Beta-3-Tubulin immunofluorescence imaging showed that prior to stretch, 
neurons exhibited highly branched, smooth neurite morphology.  After stretch, many neurons 
developed widespread focal swellings along their neurites (red arrows) (Scale Bar = 20 µm). (C) 
Quantification of neuronal injury showed an initial significant response between 0% and 10% strains 
(n ≥ 4).  Neuron loss due to stretch also increased with strain magnitude.  (D) Mechanoporation cannot 
account for the injury morphology as strain magnitudes less than or equal to 25% showed no 
significant uptake of a membrane impermeable dye following stretch (n ≥ 3).  All bars SEM for all 
panels, * p < 0.05. 
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Figure 2-2: Characterizing Substrate Strain Levels. 
(A) The high speed stretcher induces a rapid strain within the culture substrate.  (B) Strain profiles 
indicating magnitude and rate are measured by (C) high speed imaging (80FPS) of the distortion of a 
grid printed onto the substrate surface and subsequently calculating 3-point strain values (max values 
indicated here for 40% strain field).    
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2.2.2 High Speed Stretcher Injury is Focal Adhesion Density-Dependent   
The cytoskeleton of the neuron is anchored to the substrate through FAs [266] providing 
a link for force propagation in the cell (Fig. 2-4A).  We reasoned that we could control FA 
density by culturing neurons on microcontact printed surfaces coated with PLL or saturated FN. 
On PLL surfaces, extracellular matrix (ECM) deposition from media serum provides specific 
attachment sites for neuronal FAs (Fig. 2-4B). We found that neurons cultured on FN-coated 
substrates formed  FAs throughout ~25% more of their neurite area compared to PLL-coated 
substrates (Fig. 2-4C). FAs were also smaller and appeared less dense on PLL-coated substrates 
as compared to those in neurons on FN-coated substrates.  
We asked how neuronal focal adhesion density affected the neuronal injury. We coated 
the culture wells of the stretchable substrates with either FN or PLL prior to seeding them with 
neurons to regulate the density and number of FAs.  After five days in culture, we subjected the 
neuronal networks to an abrupt strain with the HSS system.  We observed an increase in the 
 
Figure 2-3: Stretch Induced Cell Death. 
The extent of induced cell death following stretch was measured using TUNEL staining at both (A) 10 
minutes and (B) 60 minutes post stretch.  Significant increases in cell death were not observed at either 
time point.  All bars SEM. 
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Figure 2-4: Substrate coating influences neuronal FA formation and injury progression. 
(A) Neurons are mechanically coupled to the substrate via FAs that couple the intracellular 
cytoskeleton to the ECM. (B)  Immunofluorescence imaging of vinculin puncta indicated the presence 
of FAs. Scale bars correspond to 8 and 10 µm, for PLL and FN respectively. Quantification of (C) 
total vinculin puncta area (n = 8) indicated that a fibronectin coated substrate induced FA formation 
over a larger area and with greater average cluster size compared to a PLL coated substrate (n = 5).  
(D) The percentage of neurons that exhibited widespread focal swelling following stretch injury was 
greater on a FN coated substrate compared to a PLL coated substrate at 10 minutes (n ≥ 4 for PLL and 
n ≥ 8 for FN). All bars SEM for all panels, * p < 0.05.   
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proportion of neurons exhibiting focal swellings on FN-coated substrates when compared to 
neurons cultured on PLL at both 5% and 10% strains (Fig. 2-4D).  Since PLL-coated substrates 
induce the formation of smaller and less dense FAs when compared to neurons cultured on FN, 
the difference in injury rates as a function of FA size and density suggests a role for an integrin-
mediated injury mechanism. In this case, abrupt stretch of the cell substrate uniformly injures the 
more robust focal adhesion architectures of the FN-seeded neurons because they are more rigidly 
adhered at networked points throughout the neuron’s soma and neurites. 
2.2.3 Injury is ROCK-Dependent  
Mechanochemical coupling may activate secondary signaling cascades which cause 
neuronal injury.  Previous reports suggest that cysteine proteases, such as calpains, actively 
degrade the cytoskeleton and that their inhibition can reduce neuronal injury [90,46]. Others, 
however, have suggested the involvement of additional or multiple pathways leading to different 
forms of neuronal injury [268,186].  We asked if a calpain inhibitor would reduce the instance of 
focal swelling in our model.  Using the HSS system with neuronal cultures seeded on PLL 
substrates, we observed that the application of MDL-28170 to inhibit calpain activation either 
before (Fig. 2-5), or immediately following, abrupt stretch yielded no significant change in 
neurite focal swelling, suggesting that calpain activation cannot explain neuronal injury in our 
model (Fig. 2-6A). Previous work has shown that integrin mediated RhoA activation may cause 
cytoskeleton reorganization, stiffening, and contraction in other cell types [188,199].  Since 
increased RhoA activity has been noted in previous in vivo TBI models [82], and more recently 
inhibition of ROCK, a downstream effector of RhoA,  has been shown to be an important 
therapeutic target in various neurodegenerative disease [206], we asked whether integrin-
activated Rho-ROCK signaling may contribute to neuronal injury in our model. Immediate 
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application of HA-1077, a ROCK inhibitor, following stretch with the HSS system resulted in a 
dose-dependent decrease in the percentage of neurons exhibiting focal swellings (Fig 2-6B).  
This apparent neuroprotective effect of HA-1077 was observed at both 5% and 10% strain 
magnitudes (Fig 2-6C). These studies suggest that a FA mediated signaling cascade may be 
converging on a ROCK-mediated pathway, identifying a series of potential targets for future in 
vivo therapeutic intervention studies following TBI.  
 
Figure 2-5: Effect of Calpain Inhibition on Injury Levels 
Neither (A) pre-administration 30 minutes prior to nor (B) post-administration immediately following 
stretch of Calpain inhibitor elicited neuroprotective effects against stretch induced focal swelling. All 
bars SEM for all panels 
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Figure 2-6:Pharmacological inhibition of secondary injury pathways may reduce neuronal 
injury. 
(A) Immediate administration of a Calpain inhibitor MDL 28170 following 10% stretch of neurons 
seeded on PLL substrates was unable to reduce the percentage of injured neurons 10 minutes later (n ≥ 
4). (B) However, immediate application of a ROCK inhibitor, HA-1077, was able to reduce neuronal 
injury in a dose dependent manner (n ≥ 5). (C) Decreases in injury were observed at both 5% and 10% 
strain magnitude (n ≥ 5). All bars SEM for all panels, * p < 0.05.   
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2.3 Discussion 
 Here we have shown that given the same mechanical stimulus, neurons exhibiting 
increased FA density are more likely to experience axonal injury.  Previous studies have 
attributed this injury to a loss of ionic homeostasis caused by either a disruption of the cell 
membrane [104,153,90] or changes in ion channel function [262,305].  However, we have shown 
that injury can be induced by applying small strains, less than what can disrupt the cell 
membrane, at high rates directly through mechanically sensitive FAs. A recent in vitro study 
directly linked focal swelling to the pathological influx of calcium and activation of calpains 
which degrade the cytoskeleton [153].  Other studies have shown that not all neuronal injury is 
dependent on membrane disruption and calpain activity [90,268], but offer little evidence for an 
alternative mechanism to account for the calpain-independent injury. Our in-vitro study indicates 
that integrin mediated Rho-ROCK activation may account for calpain independent pathways of 
injury.  
Concurrent with this study, our group showed that axons may be more vulnerable to 
injury than the soma because the failure strength of FAs in neurites is significantly lower than in 
the soma.  Furthermore, force transmission via integrin binding ECM proteins always produced 
widespread focal swelling, whereas non-specific force transmission through the membrane 
produced only local injury [126].  A previous study has demonstrated a similar sensitivity of 
neuronal injury to ECM composition in the 3D cell microenvironment [43]. Neurons embedded 
in a 3-D gel composed of collagen conjugated to agarose exhibited increased cell death following 
an acute, high rate deformation when the collagen concentration was increased, indicating that 
the degree of cell-ECM contacts may influence neuronal injury [69].  Cell-matrix interactions 
have also been shown to be involved in pathological processes following acute mechanical 
stimulation in other cell types such as vascular smooth muscle cells [302] and epithelial cells 
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[283,32].  These reports, coupled with the data reported herein, suggest ECM-cell adhesions may 
be important conduits for mechanical cell trauma.   
Previous reports suggest a role for calpains in neuronal injury [153,90,268].  In our low 
strain model, we were unable to mitigate neuronal injury with a calpain inhibitor.  However, we 
were successful in reducing neurite injury with the use of a ROCK inhibitor.  Integrin stimulation 
can activate many signaling cascades, but activation of the Rho-ROCK pathway is of particular 
interest because of its known effects on the cell cytoskeleton. ROCK activation can affect 
cytoskeleton remodeling by activating downstream targets that regulate cytoskeleton tension 
[154], actin polymerization [217], neurofilament depolymerization [125], and microtubule 
stability [9].  Interestingly, studies have shown that axon focal swelling may be a result of the 
breakdown of microtubules and impairment of the axonal transport system [151].  Furthermore, 
axon retraction following mTBI can be linked to active remodeling of the neuronal cytoskeleton 
[178].  The activation of RhoA in in vitro studies has demonstrated neurite retraction in 
neuroblastoma cell lines [143] and dendritic retraction in brain slices [33].  A genetic study in 
Drosophila indicates that in mature neurons, the RhoA-mediated axon retraction pathway is 
actively repressed by negative regulators [31].  The synaptic degeneration associated with DAI 
implies that the activation of RhoA is a maladaptive response.  Blocking activation with a Rho 
antagonist can reduce injury related apoptosis in the CNS [83], suggesting that blocking Rho 
activation may be effective in treating TBI.  Furthermore, recent studies on axon growth cone 
retraction have demonstrated a link between ECM protein type, integrin activation, cyclic AMP 
levels, and Rho activity [169].  With the growing concern about the lack of therapeutic options 
for treating mTBI [145], our results suggest that further exploration of cellular 
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mechanotransduction mechanisms associated with ECM-cell adhesions may identify novel 
therapeutic opportunities.   
This chapter has focused on introducing the concept that axonal injury may be affected 
not only by the magnitude or rate of applied insult, but also by mechanochemical coupling at the 
focal adhesion.  We utilized a standard in vitro TBI model with a subtle, but important 
modification to substrate surface chemistry to indicate that mechanosensitive properties of the 
neuron must also be considered in addition to the mechanics to fully understand the neurons 
response to trauma forces.  This is equivalent to saying that the neuron is not a passive material, 
but has an active response to applied force.  Future chapters of this dissertation will aim to 
elucidate additional factors that influence this active response. 
2.4 Materials and Methods 
2.4.1 Ethics Statement 
All procedures were approved by the Harvard Animal Care and Use Committee under 
Animal Experimentation Protocol permit number 24-01.  This protocol, entitled "Harvest and 
Culture of Neural and Cardiac Tissue from Neonatal Rats and Mice for In Vitro Disease 
Models," meets the guidelines for the use of vertebrate animals in research and teaching of the 
Faculty of Arts and Sciences of Harvard University. It also follows recommendations included in 
the NIH Guide for the care and use of laboratory animals and is in accordance with existing 
Federal (9 CFR Parts 1,2&3), state and city laws and regulations governing the use of animals in 
research and teaching. 
2.4.2 Neuron Harvest and Culture 
Cortical neurons were isolated from 2-day old neonatal Sprague-Dawley rats (Charles 
River Laboratories, Boston, MA). Reagents were obtained from Sigma-Aldrich (St. Louis, MO) 
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unless otherwise indicated. Cortices were surgically isolated and minced in Hanks’ balanced salt 
solution (Invitrogen, Carlsbad, CA) followed by digestion with trypsin (USB, Santa Clara, CA) 
overnight at 4°C.  The cell suspension was then filtered through a nylon filter of 40µm pore size 
(BD Bioscience) and finally separated using a Percoll gradient (GE Healthcare Life Sciences, 
Piscataway, NJ). Subsequently, cells were re-suspended in DMEM culture medium (Invitrogen) 
supplemented with 10% (v/v) heat-inactivated fetal bovine serum (Invitrogen), 30 mM Glucose, 
2mM L-glutamine, 25 mM KCl, 50 mU Insulin, 7µM p-Aminobenzoic acid, 100 U/mL 
penicillin, and 100μg/mL streptomycin. Cells were seeded at a density of 30,000 cells per cm2 
and supplemented with 10 µM cytosine arabinoside for the first 48 hours of culture on substrates 
coated with either 100µg/ml PLL or 50 µg/ml FN. Samples were incubated under standard 
conditions at 37°C and 5% CO2. After 48 hours cells were washed 3 times with PBS to remove 
non-adherent cells.  Media was replaced every 48 hours until experiments were executed. All 
experiments were performed on either day 4 or 5 post seeding. 
2.4.3 High Speed Stretcher in vitro TBI Model 
 Medical grade silicone elastomer membranes   (SMI .010” NRV) were spin-coated with 
Sylgard 527 (Dow Corning, Midland, MI) polydimethylsiloxane (PDMS) that was mixed at a 1:1  
base to curing agent ratio and allowed to cure for at least 4 hours at 70oC.  The elastomer 
membranes were then clamped into custom made brackets to maintain tension, and a reducing 
well to hold cell media was adhered using additional PDMS which was allowed to cure again for 
at least 4 hours at 70oC.  Samples were then oxidized using UV ozone (Model No. 342, Jetlight, 
Irvine, CA) for 8 minutes to sterilize the surface and increase hydrophilicity for protein 
adsorption.  Either isotropic Poly-l-Lysine (PLL) or Fibronectin (FN) (BD Biosciences, San Jose, 
CA) was then deposited on the PDMS at a concentration of 100 µg/ml or 50 µg/ml, respectively, 
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in sterile deionized water for at least 20 minutes.  Excess PLL or FN was removed by washing 
with deionized water.  Neurons were seeded and cultured inside the reducing well as indicated 
previously.  Each sample was loaded into a custom made High Speed Stretching (HSS) device 
which used a high precision linear motor (LinMot Model P01-23x80F-HP, Elkhorn, WI) to 
displace the brackets and strain the elastomer sheet to a desired magnitude at a rate of 1% per ms 
(Movie S1).  Membrane strain was verified by recording the deformation of a 1x1 cm grid using 
a high speed camera (FasTec Troubleshooter Model #: TS1000ME) and calculating the strain 
using a three-point strain algorithm [8].   
2.4.4 Immunofluorescent Staining and Microscopy 
 Cells were washed 3 times in PBS at 37oC and fixed for 10 minutes in 4% 
paraformaldehyde and 2.5% TritonX-100 in PBS at 37oC.  Cells were then washed 3 times in 
PBS and an initial blocking step using 5% Bovine Serum Albumin (Jackson ImmunoResearch, 
West Grove, PA) in PBS was performed for 1 hour at 37oC.  The blocking solution was aspirated 
away and the primary antibody solution was immediately added and incubated for 1.5 hours at 
room temperature.  The primary antibodies used were either anti-β-Tubulin III (1:200), 
monoclonal anti-Vinculin (1:200), or  anti-glial fibrillary acidic protein (1:200).  Primary 
antibodies were added to a 0.5% BSA in PBS solution.  Following primary staining, cells were 
washed 3 times, and the secondary staining solution consisting of either goat anti-mouse 
conjugated to Alexa-Fluor 488 or goat anti-rabbit conjugated to Alexa-Fluor 546 and 4’,6-
diamidino-2-phenylindole (DAPI) was added to the cells for 30 minutes at room temperature.  
Samples were then washed 3 times.  For samples seeded on silicon sheets, a scalpel was used to 
cut out an 18mm circular section of the substrate which was placed on a glass slide.  For glass 
bottom samples, the glass was removed from the dish and placed on a glass slide.  ProLong Gold 
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Antifade reagent (Invitrogen) was added to preserve the samples and glass coverslips are affixed 
using nail polish (company info).  Prepared slides were either imaged immediately or stored at -
20oC. Imaging was performed on a LSM 5 LIVE confocal microscope (Carl Zeiss, Oberkochen, 
Germany) with appropriate filter cubes.     
2.4.5 TUNEL Assay 
Click-iT TUNEL assays (Invitrogen) were performed following the manufacturer’s 
protocol [211]. Briefly, cells were fixed in 4% paraformaldehyde and fragmented strands of 
DNA were labeled with a fluorescent indicator.  Fluorescence imaging was performed on 
experimental and control populations, and neurons exhibiting fluorescence levels above a 
threshold set by control samples were considered to be apoptotic.    
2.4.6 HSS Membrane Poration Studies 
Immediately prior to HSS experiment, membrane impermeable fluorescein dye 
(Invitrogen) was added to the cell media at a 10µM concentration.  Following completion of the 
experiment, samples were fixed as described previously but TritonX-100 was excluded.  Cell 
nuclei were labeled with DAPI as described earlier.  Uptake of the dye was determined by 
fluorescence microscopy.  Cells exhibiting uptake of the dye above a set fluorescence intensity 
threshold of three standard deviations greater than the control mean were considered to be 
porated. 
2.4.7 Vinculin Puncta Quantification  
Using a watershed algorithm to separate neighboring structures according to the intensity 
‘valley’ between them, individual FAs could be identified and their respective area quantified. In 
order to segment very large and granular adhesion sites, as observed on FN- and PLL-coated 
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substrates respectively, we used a different set of threshold values for watershed segmentation 
[149,317]. 
2.4.8 Pharmacological Interventions  
Calpain inhibitor MDL 28170 (Sigma) was prepared per manufacturer’s 
recommendations. Briefly, MDL 28170 was reconstituted in anhydrous DMSO and neurons 
were treated with concentrations ranging between 100nM and 1mM in Tyrode’s solution. The 
effects of the calpain inhibitor were determined for both 30 minute pre-incubations and 
immediate post stretch applications. Rho-associated Kinase (ROCK) inhibitor HA-1077 (Sigma) 
was prepared by dissolving in water and neurons were treated with concentration ranging 
between 1nM and 100 μM in Tyrode’s solution.  The effects of calpain inhibitor were 
determined for immediate post stretch applications.   
2.4.9 Statistical Analysis  
Statistical significance was measured by ANOVA and subsequent pairwise comparison 
when comparing multiple values. p<0.05 for all statistically significant differences.   
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3 Developing a Tool Set for Localizing Injury Forces through Specific 
Subcellular Structures 
3.1 Introduction 
Following the implication of mechanochemical coupling in axonal injury, we sought to 
pursue the importance of trauma forces directed through specific brain extracellular matrix 
(ECM) components in axonal injury.  However, to address the primary limitations of our 
previous work as well as to facilitate future in vitro axonal injury studies focusing on cellular 
mechanotransduction mechanisms, we identified 3 technological limitations that were necessary 
to address prior to moving forward.     
While the previous study was performed using an established in vitro model of Traumatic 
Brain Injury (TBI), we identified no suitable existing model that would allow the isolation of 
forces through specific ECM components while providing sufficient control over additional cell-
ECM influences.  Previous reports have summarized the existing models of TBI as well as their 
features [201].  To address this shortcoming, we identified an established technique called 
Magnetic Twisting Cytometry (MTC) [295,292,87,194,5,196,210] that could be adapted as an in 
vitro model of TBI and that could provide the necessary level of control for directing injury 
forces through specific brain ECM components.   
Although traumatic damage to all neural cell processes is likely, Diffuse Axonal Injury 
(DAI) is focused specifically on neuronal axons.  In order to isolate our study to axons, we 
developed improved seeding and cell culture methods that provided axon rich regions in which 
injury analysis could be isolated.  This was accomplished through the combination of mask 
seeding and microcontact printing [304] into a technique termed stamp mask culturing. 
Finally, since the primary form of pathology associated with DAI is a morphological 
change within the axon, specifically axonal focal swelling, and visual confirmation of injury is 
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an acceptable form of analysis.  However, in order to minimize the influence of user bias, 
maximize the efficiency and consistency of analysis, and to provide increased complexity of 
analysis we sought to develop an automated method to quantitatively identify and measure 
axonal injury.  To do so, we developed a protocol combining semi-automated imaging of live 
neuronal cultures with post image analysis in both ImageJ and Matlab to identify and 
quantitatively measure the extent of axonal injury in vitro.      
3.2 Development of an in vitro TBI Model for Delivering Localized Injury Forces 
through Specific Subcellular Structures 
3.2.1 Design Criteria for the Development of an in vitro TBI Model Capable of 
Localizing Forces at the Subcellular Level 
In order to address the experimental task of investigating brain ECM-cell interaction 
mechanisms in axonal injury, we built an  in vitro device that allows the localization of well 
defined mechanical stimuli through specific ECM proteins to their receptors on the cell surface.  
The development of a new device was required because there are currently no in vitro assays that 
allow enough precision to isolate injury forces to multiple cellular sites across multiple cells 
while minimizing global cell strain that results in non-specific force application.  MTC is a 
technique that  is similar to the magnetic tweezer based technology that has previously been used 
in our lab to study axonal injury, but it has previously been used only to study the mechanical 
and mechanosensitive properties of cells [293].  We chose MTC because it provided a means to 
direct localized forces to multiple axons simultaneously through specific ECM-coated 
microbeads and is known to be compatible with live cell imaging.   
3.2.2 Building the MTC in vitro  Model of TBI 
MTC delivers localized forces to cells by manipulating small ferromagnetic beads (~5µm 
diameter) bound to cell surface receptors.   Microbeads are rapidly rotated by applying an initial 
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magnetizing magnetic pulse (~.1T or 1000 G) followed by an orthogonal twisting magnetic pulse 
(~.01T or 100G). To use this technique as a means to direct injury inducing forces to our cell 
populations, we designed and built the necessary device components in house.  Four primary 
components were designed (Fig 3-1A). Charging circuitry converts a standard 110 volt power 
input to as much as 1 kV for charging the capacitor bank.  The capacitor bank  consists of 
multiple 10 uF and 900 uF units and stores charged energy to be rapidly discharged through the 
coils.  Due to the electric circuit design (Figure 3-2), the output current can be modeled as a 
simple RLC circuit whose waveform morphology is dictated by the circuit resistance, 
inductance, capacitance, and charge voltage.  A pulse shaping network is used to modify the 
characteristic resistor-inductor-capacitor (RLC) circuit transient into a waveform with 
appropriate duration and morphology for magnetizing and twisting the beads.  Field generating 
coils convert the discharged electric current into a transient magnetic field. The first three 
components are combined into a single, mobile power supply cart which allows the user to select 
appropriate charging voltage as well as discharge waveform duration (Fig. 3-1B).  Both coils 
were initially designed using computer aided drafting (CAD) software (Fig 3-1C,E) prior to 
actual fabrication (Fig 3-1D,F). The twisting coil includes several important design aspects that 
facilitate long term live cell imaging of a cell sample following bead twisting.  These design 
features include the incorporation of the coils into a standard microscope stage insert and a 
closed environmental chamber with cover glass lid to minimize contamination and evaporation 
during long term microscopic imaging.  Each coil was designed in a helmholtz configuration to 
maximize field uniformity.  Simulations were used to direct the design of the coils, and 
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Figure 3-1: Magnetic Twisting Cytometry Device as an in vitro model to study TBI. 
(A) Four primary MTC device components were designed and constructed in house.  (B) The high 
voltage charging circuitry, capacitor banks, and pulse shaping network are housed in a single cart both 
safety and convenience.  (C,E) Both the magnetizing and twisting coils were designed using CAD 
software and supported by simulations of magnetic field generation.  (D,F) The coils were fabricated 
in house and adapted to facilitate long term live cell imaging by incorporating the twisting coil into a 
standard microscope stage and including a closed cell chamber to minimize contamination and 
evaporation of bath solution.      
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following coil construction, we verified the design parameters by directly measuring the 
magnetic fields generated by each coil using a small magnetometer probe. The magnetic field 
magnitude and orientations were measured in the center of each coil pair, corresponding to the 
location in which the culture dish sits,  while the current driven through the coil was increased 
(Fig. 3-3 A-B).  As exected, we observed a linear increase in field magnitude along the axis of 
the coil (inset indicates each direction relative to the coil cross section).  Measurement of the 
slope of this line allowed us to convert current through the coils to magnetic field magnitude for 
 
Figure 3-2: Schematic Diagram of MTC Power Supply. 
The magnetic twisting cytometry device is driven by a high voltage power supply designed based on a 
simple resistor-inductor-capacitor (RLC) circuit.  A standard 110 volt wall outlet is converted to high 
voltage through a proprietary circuit.  The high voltage outlet then charges a capacitor bank of 900 µF 
and 10 µF capacitors up to 1 kV.  The capacitors are subsequently discharged through a circuit 
consisting of the coil and a series resistance that is modified to produce transient currents of specified 
magnitude and duration.  Multiple safeguards are built into the power charging circuitry to protect 
users from potentially dangerous current discharges.  
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Figure 3-3: Two pairs of electromagnetic coils each in a Helmholtz configuration are used to 
generate the magnetic fields required for the MTC injury model. 
(A) A magnetizing coil is used to initially magnetize small ferromagnetic beads and a (B) twisting coil 
is used to provide a subsequent orthogonal field causing the beads to rotate and generating a stress at 
the site of adhesion to the cell.  (C-H) The magnetic field strengths and distributions were measured 
with a magnetometer to verify the experimental design parameters. 
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both the magnetizing coil (.7 Gauss/Amp) and the twisting coil (160 Gauss/Amp).  This also 
verified that the axial field was much greater in magnitude than either orthogonal field 
magnitude components. The uniformity of the generated magnetic field was also  measured by 
moving the magnetometer probe in both the axial and radial directions (Fig. 3-3C-F) while 
keeping the current through the coils constant. As expected, we observed uniform fields within 
the constraints of the coil (indicated by the dashed lines).  Uniformity in field magnitude is 
important in order to ensure consistent bead torque at all locations within a coverslip.  
 Twisting of the microbeads is accomplished by applying a transient magnetic field in an 
orthogonal direction to the microbead magnetic moment resulting in a torque: τ = M x B (Fig. 3-
4A).  The ferromagnetic beads are exposed to a brief, large magnetic field (Fig. 3-4B) generate 
and align the magnetic moments followed by a brief twiting coil (Fig. 3-4C) that produces the 
torque.  The degree of magnetization is indicated by the magnetic moment, which can be 
calculated by measuring the decay of the remnant magnetic field as the beads rotate to align with 
a known twisting field in a medium of known viscocity.  We placed a high concentration of 
ferromagnetic beads in glycerol (Fig. 3-4D), magnetized the beads in one direction, and 
subsequently applied a low magnitude twisting field in an orthogonal direction.  We used a 
magnetometer to measure the remnant magnetic field strength in the original magnetized 
direction and observed an exponential decay in field magnitude (Fig. 3-4E).  An exponential fit 
provided the decay constant which, combined with solution viscosity, bead dimensions, and 
physical constants, was used to calculate the effective stress delivered by each bead [294].  From 
these results, we calculated a bead calibration factor of 0.314 Pa/Gauss which indicates the 
effective stress delivered by each bead for a given field strength.  This data, in combination with 
the coil properties previously measured in Figure 3-3, allow the calculation of the bead stress 
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induced by delivering a current pulse through the twisting coil. Two limitations currently exist in 
determining the exact shear force at the bead adhesion site.  First, the force is dependedent upon 
the surface area of bead binding, and precise imaging studies are needed to experimentally 
measure this value.  Second, the bead rotation cannot currently be measured in real time.  
Therefore, stimulus values will be reported as the max shear stress delivered by each bead, which 
is dictated by the peak current discharged through the coil. 
 In addition to microbead twisting, there is a small degree of microbead translation that 
will produce a localized strain.  High speed imaging during the application of the twisting field 
captures the projection of bead translation (Fig. 3-4F).  Tracking the motion of the centroid of 
multiple beads (N>100) we measured a typical motion profile (Fig. 3-4G).  The motion profile 
 
Figure 3-4: Measurement of the induced bead magnetic moment allows for calculation of the 
induced bead torque for a given magnetic field strength. 
(A) Small ferromagnetic beads were placed in a solution of glycerol. (B) The beads were initially 
magnetized and then exposed to a twisting field while the remnant magnetization along the original 
magnetization axis was measured in time.  The magnetic moment can be is proportional to the 
exponential decay time constant.    
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indicated an absolute displacement of ~.75 μm that occurred over the 50 ms of applied twisting 
field with a subsequent relaxation to near its original location by ~ 300 ms.   
A primary feature of the MTC device is that it can deliver mechanical stimuli at multiple 
sites across multiple cells in a single sample.  However, just as important is its ability to direct 
these injury forces through microbeads coated with specific proteins or ligands that target 
specific cell surface receptors.  In order to verify microbead coating with proteins of interest, we 
utilized a basic chemical reaction producing covalently bonded protein coating on the bead 
surface.  The covalent bond was accomplished using a two pot reaction process (Fig 3-5A).  The 
initial step consisted of carboxyl coated microbeads (CFM 40-10, Spherotec)  incubated with 100 
μM 1-Ethyl-3-(3-dimethylaminpropyl)carbodiimide) (EDC) and 100 μM N-Hydroxysuccinimide 
(NHS) in a 1.0 M Sodium Acetate Buffer for 1 hour at room temperature.  The microbead 
mixture then underwent a 3x series of centrifugation at 500 G for 1 minute and a subsequent 
rinse with isotonic buffered saline.  The second reaction step consisted of adding the protein of 
interest at a concentration of 1μM in isotonic buffered saline overnight at 4 oC.  The final coating 
step consisted of incubating the microbeads in 1% Bovine Serum Albumin (BSA) for 1 hour 
(also served as storage solution for up to 3 days).   
Following microbead coating, the presence of protein on the microbead surface was 
verified using multiple techniques.  We utilized X-ray photoelectron spectroscopy (XPS) to 
assess the elemental composition of the bead’s surface. After incubating beads with fibronectin 
(FN), a CAM previously used to injure neurons in our studies, beads analyzed via XPS showed 
marked increase in nitrogen content (Fig. 3-5B). This, combined with the decrease in chromium 
content, suggest successful FN binding since the carboxyl-coated chromium oxide surface of the 
bead is now covered with nitrogen-containing FN. Moreover,  we observed  more positive zeta 
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potential of the bead following incubation with proteins including Acetylated Low Density 
Lipoprotein (AcLDL), poly-l-lysine (PLL), and FN (Fig. 3-5C), which suggest successful bead 
coating as the protein coatings shield the uncoated bead’s more negative carboxyl groups. To 
more specifically determine whether proteins were attached to the beads, we imaged beads 
coated with fluorescently tagged AcLDL, PLL, or FN (Fig. 3-5D-E). The normalized 
fluorescence intensity of beads revealed increased signal intensity relative to uncoated beads 
(Fig. 3-5F), which indicated that proteins were bonded to the bead’s surface. We next sought to 
characterize the ability of beads with various protein coatings to bind neurons. To this end, we 
seeded 1 million microbeads per well resulting in a saturating coverage of microbeads  (Fig. 3-
5G) and allowed the microbeads to adhere for 30 minutes.  For normal experiments, the 
microbeads were not perturbed, providing a conistent likelihood for an axon to be in close 
proximity to a microbead independent of the microbead coating.  Only for the purpose of 
determining if microbead attachment differed significantly with microbead coating, a subset of 
samples were gently rinsed, fixed, and immunostained (Fig. 3-5H).  The number of bound beads 
per unit length of axon was calculated by counting the number of beads across 1-10 mm of axon. 
This preliminary analysis revealed variable bead binding with no statistically significant 
difference in neuronal bead binding for AcLDL, PLL, or FN coatings (Fig. 3-5I), however, due 
to high variation in the bead binding the rinsing step was omitted from all injury studies. Since 
beads coated with different proteins attached to neurons to similar degrees, the observed 
differences in injury rates are likely a function of the specific nature of bead-neuron interactions 
and not because of differences in net applied force to neurons.  
48 
 
  
 
 
Figure 3-5: Verification of microbead coating with specific ligands. 
(A) CAM ligands such as ECM proteins can be covalently bonded to the microbeads in order to target 
specific molecules that may potentiate brain injury. AcLDL binds a specific membrane receptor that 
is not a CAM and serves as a control for injury experiments.  PLL beads binds non-specifically 
through charge interaction and serves as another control for injury experiments.  FN is an ECM 
protein that binds specific CAMs such as integrins.  Microbead coating can be verified through 
multiple techniques including (B) measurement of bead surface composition, (C) measurement of 
bead surface charge, and (D-F) identification of fluorescently tagged CAMs.  Following bead coating, 
adhesion to neurons is accomplished by (G) seeding a high concentration of microbeads followed by 
a 30 minute incubation period and a gentle rinse to remove unbound beads.  The number of bound 
beads remaining can be quantified by fluorescently labeling (H) the axons with a neurofilament 
antibody and (I) counting the average number per length of axon, which indicated slight differences 
in the extent of binding between coatings. 
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3.2.3 Testing the MTC Device as an in vitro Model of TBI 
Following characterization of the coils and the microbead rotation and translational 
motion, initial experiments were performed to determine the axonal response to a mechanical 
stimulus delivered by the MTC device.  Using a low throughput magnetic tweezer model,  we 
have previously shown that an acute mechanical pull on Fibronectin (FN) coated beads bound to 
neurons results in neurite focal swelling and subsequent retraction.  We sought to reproduce 
these results using the new MTC model to verify that MTC could in fact injure axons.  Control 
experiments showed no morphological changes in response to experimental conditions or to bead 
binding over a 4 hour time window indicating the experimental conditions were not inducing a 
noticeable injury within the population of neurons (Fig. 3-6A-B).  However, application of a 
single twist using the maximum applied load of 125 Pa per bead resulted in focal swelling within 
1 hour post stimulus (Fig. 3-6C).  This response was observed in multiple cells on a single 
coverslip indicating that the MTC device was able to reproduce the characteristic changes in 
axonal morphology consistent with axonal injury in multiple cells simultaneously.   Furthermore, 
we were able to track these changes in ~25 neurons on a single coverslip which drastically 
increased our experimental throughput compared to the previous magnetic tweezer model which 
allowed for analysis of only a single neuron.   
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Figure 3-6: Preliminary experiments showed that the MTC device could induce the similar 
neuronal-axonal injury responses previously observed. 
(A1-2) Control experiments consisting of time lapse imaging of neurons under experimental 
conditions with and (B1-2) without beads attached indicated neurons did not exhibit characteristic 
morphology changes over a period of 4 hours.  (C1) Mechanical stimulation by the MTC device was 
able to produce the characteristic morphology of focal swellings (arrows) at (C2) 1 hr post bead twist.     
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After verifying the induction of axonal injury, a set of control experiments was performed 
in order to determine if evidence of mechanoporation was observed during the MTC  mechanical 
stimulus. In order to rule out this potential event, we performed live, high speed calcium (Ca2+) 
imaging during the application of the twisting field.  FN coated beads were attached to neurons 
and identified using DIC imaging (Fig. 3-7A).  Neurons were then loaded with Fluo4, a Ca2+ 
sensitive fluorescent dye, whose fluorescence level is dependent upon the intracellular 
concentration of Ca2+.  This allowed simultaneous measurements of Ca2+ concentrations at 
multiple locations along the axon (Fig. 3-7B).  Due to the large calcium gradient that exists 
across the cell membrane, if the membrane is torn one would expect to see a rapid increase in 
intracellular Ca2+ levels corresponding to a spike in the Fluo4 signal.  In order to test whether 
such an increase occurs during the mechanical stimulus delivered by the MTC device, we 
recorded from a neuron loaded with Fluo4 at 250 frames per second (FPS) during a single bead 
twist.  We analyzed the intensity of the fluorescence signal over this time interval (Fig. 3-7C).  
We observed physiological calcium cycling due to action potential firing but did not observe any 
change in Ca2+ signal during the twist (black arrow).  While we cannot rule out 
mechanoporation, we can conclude that if there is a transient tearing of the membrane the 
resulting Ca2+ flux is much less than that which occurs in the normal axon and thus should not 
account for the pathological changes observed at later time points.  
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In order to better understand the extent of axonal injury induced by the MTC model, we 
tested analyzed injury rates in neuronal cultures of varying age and varying stimulus intensity.   
We have previously performed our injury assays on primary cortical neurons harvested from day 
2 neonatal Sprague Dawley rats and cultured for 5 days in vitro (DIV).  Neurons at this stage, 
although generally considered immature, exhibit long branched neurites that exhibit injury 
responses similar to that observed in more mature cells.  However, neurons are not typically 
considered mature until 14-21 DIV.  Therefore, in order to accommodate this as well as to 
maintain consistency with previous results, we performed MTC injury experiments on neurons 
cultured for 5 and 19 DIV.  We also compared the injury rates in response to twisting field 
 
Figure 3-7: Measuring bead twisting  induced intracellular calcium (Ca2+) increase as a marker 
of mechanoporation. 
(A) DIC image of a neuron prior to bead twisting illustrates bead binding location and sites analyzed 
for Ca2+ fluorescence.  (B) Immunofluorescence image illustrates a single snapshot taken at 250 fps 
during the bead twist.  (C) Example regions show raw Ca2+ fluorescence intensity signal at each 
location illustrated in the images.  The dashed line illustrates the approximate time of the bead pull, 
but no spike is observed in Ca2+ intensity, suggesting that the neuron is not experiencing 
mechanoporation.   
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strengths corresponding to capacitor charges of 20 and 100 or induced shear stresses of 6 and 30 
Pa per bead, respectively.  As expected, we observed a magnitude dependent incidence of neurite 
focal swelling, in the DIV 19 cells, but we were unable to induce consistent levels of elevated 
injury rates in the DIV 5 neurons (Fig. 3-8A).  One explanation for this is that the magnitude of 
the mechanical stimulus delivered to each neuron using the MTC injury model may be less than 
that of previous injury models and insufficient to generate large amounts of injury across the 
entire coverslip.  Interestingly, we did observe neurite retraction, another indicator of injury, in 
both DIV 5 and DIV 19 neuronal cultures indicating that there is a response to the mechanical 
stimulus even in the less mature cultures (Fig. 3-8B).  Nonetheless, it is an important potential 
result in that future in vitro studies may need to qualify their results based upon the maturity of 
their cultures.  All future injury studies will be performed on the mature 14-21 DIV neuronal 
cultures.   
 
 After verifying that the MTC model can reproduce our previous neuronal injury results, 
we continued our efforts to understand the effects of directing trauma forces through specific 
ECM components.  Building on our previous results using the high speed stretch injury model, 
we compared the extent of axonal injury induced by directing forces through PLL coatings 
compared to FN coatings.  PLL will interact non-specifically with the cell membrane due to its 
large positive charge, yet has no specific ligand-receptor interaction, whereas FN is known to 
bind specifically to multiple integrin subunits. To this end, we performed live imaging 
experiments on neurons subjected to MTC stimulus through where multiple neurons from each 
culture sample were imaged every 5 minutes for one hour allowing timelapse images to be 
constructed for each neuron.  The percentage of neurons that had become injured, indicated by 
the presence of axonal focal swellings, at each timepoint was recorded for each sample condition 
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(Fig. 3-9A).  The results indicated that the progression of injury was different in neurons injured 
through PLL coated beads compared to those injured through FN coated beads.  A significant 
different in injured neurons was observedat 10 minutes following injury but not at 60 minutes 
(Fig. 3-9B).  Additionally, using a sigmoidal fit to the data, a significant difference was observed 
in the time to 50% of maximum injury percentage (Fig. 3-9C).  Together, this data shows that 
forces delivered through FN coated beads injured neurons quicker than PLL coated beads 
suggesting a difference in the the cellular response to the applied stimulus.  This is important 
because it supports our previous implication of ECM-cell adhesion in axonal injury and supports 
the hypothesis of integrin mediated injury.   
 
Figure 3-8: Neuronal injury identified in vitro may be dependent upon the days in culture. 
(A) Neurite focal swelling exhibited an age and magnitude dependent response using the MTC injury 
model.  (B) Neurite retraction depends upon stimulus magnitude but occurred independent of how 
long the neurons were cultured. 
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To better understand the differences in injury progression observed between FN and PLL 
coated beads, we aimed to determine the structures through which these beads adhere to the 
neuron.  A primary advantage of the MTC technique is that it allows us to control the cellular 
structures through which injury forces are delivered by coating the beads with different proteins.   
Our hypothesis posits that injury forces encountered during mTBI couple to the neuronal 
cytoskeleton via mechanically sensitive, transmembrane proteins. One class of such proteins 
includes integrins, which are a family of transmembrane proteins that mechanically couple the 
intracellular cytoskeleton of cells to the extracellular space through focal adhesion complexes 
[292,5,293]. Alternatively, other proteins which do not bind integrins will not result in focal 
adhesion formation.  To test this, we attempted to immunostain for both focal adhesion markers, 
such as vinculin, and for integrins themselves.  We have been successful in identifying evidence 
of focal adhesion formation near FN coated beads.  We observed an increase in the localization 
of both vinculin (Fig. 3-10A)  and  β1 integrin (Fig. 3-10C) to areas of the axon bound by FN 
coated beads suggesting that the mechanical actuation of these beads engages integrin proteins 
 
Figure 3-9: Bead coating affects injury rate. 
(A) The percentage of neurons exhibiting injury by the indicated time point is recorded for both FN 
and PLL coated beads. (B) A significant difference in injured percentage is observed at 10 minutes but 
not at 60 minutes following bead twist corresponding to 30 Pa max shear strain.  (C) Using a 
sigmoidal fit to the data, FN induces injury at a significantly earlier time point than PLL. 
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and is directly transferred to the cytoskeleton of the neuron.  Brightfield images indicate the 
location of bound beads with respect to the axon (Fig. 3-10B,D). Although the colocalization 
appears more prominent in area of FN bead attachment compared to PLL beads, we unable to 
produce consistent immunostaining results such that a quantitative analysis could be performed.  
Therefore, a current limitation exists in that the specific membrane receptors and specifically cell 
adhesion molecules that are coupled to the ECM coated microbeads is unclear.  This is likely due 
to the difficulty of stabilizing these transient structures during the fixation procedure as well as 
their small clustering size compared to other adherent cell types.  Future work will be necessary 
to clarify the specific structures through to which these ECM coated beads adhere in neurons.   
 
 
Figure 3-10: Fibronectin coated ferro-magnetic beads bound to neurons recruit integrins and 
focal adhesion components. 
(A) Immunostaining for vinculin (green) reveals the presence of focal adhesions (white arrows) where 
beads attach to neurons (neurofilament: red). (B) β1 integrins also cluster at bead adhesion sites. (C,D) 
Bright field images confirm bead colocalization with vinculin and integrin immunofluorescence 
images. Scale bar = 5 µm. 
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3.3 Development of Anisotropic Neuronal Substrates to Isolate Axon Rich Regions 
3.3.1 Design Requirements for Neuronal Cultures with Isolated Axons 
Axonal swelling is the hallmark morphology of DAI and thus remains the most definitive 
means of identifying injured axons in vitro.  Unfortunately, due to the intricate structures of 
neurons and glial cells, it is often difficult to accurately identify these markers.  Part of the 
difficulty lies in the fact that neuronal cultures are typically isotropic and densely seeded to 
promote viability.  In our previous work, we seeded our cultures sparsely in order to increase the 
likelihood of finding isolated neurons.  However, sparse neuronal cultures do not maintain their 
viability well over the long term culture period necessary for maturation (14-21 DIV).  
Furthermore, by definition DAI is an injury to axons.  While it is unlikely that dendrites are 
immune to damage, their injury response may vary from that of axons and therefore it may be 
beneficial to separate these two types of processes in the experimental setting.  As is evident 
from a typical neuronal cortical culture, most neurons exhibit a highly branched, complex tree of 
processes consisting of a mixture (Fig. 3-11).  While immunolabeling techniques as well as 
subtle morphological differences can distinguish dendritic and axonal processes, clear distinction 
between these two subsets is often difficult.  In order to facilitate studies of axonal injury, it is 
therefore beneficial to introduce a level of anisotropy into the neuronal cultures such that axons 
are (1) isolated from dendritic and glial processes, (2) concentrated in a single region to increase 
analysis throughput, and (3) aligned to decrease the effects of overlapping or directional effects 
of force application. 
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3.3.2 Building Stamp Masks to Produce Neuronal Cultures with Isolated Axons 
Many strategies have been used successfully to introduce anisotropic cues to cultured 
cells.  We utilized a combination of mask seeding and microcontact printing [304] in a technique 
termed stamp mask cultures to produce regions of isolated axons with specific degrees of 
alignment (Fig. 3-12).  Mask seeding uses a physical barrier to prevent cell bodies from adhering 
to regions of a coverslip during the seeding process.  Microcontact printing utilizes microscale 
features imprinted onto the surface of a polymer, typically PDMS, that are inked with adhesive 
protein and then transferred to a substrate surface.  The resulting printed chemical cues direct cell 
adhesion along certain paths presenting specific boundary cues to the cell.  We combined these 
two techniques by initially molding microscale lines that were  1cm x 15 μm x 5 μm (L x W x H) 
into one surface of a 1 mm thick slab of PDMS.  After molding one surface, an epilog CO2 laser 
 
Figure 3-11: Isotropic Neuron with Highly Branched Processes. 
Example image of a neuron after 14 days in culture illustrates the extensive branching of its processes.  
The distinctive morphology presents multiple challenges to identifying axonal injury including 
distinguishing axons and dendrites, attributing a particular axon to a cell body, and quantifying the 
degree of axonal injury within a given process.  The isotropic morphology also results in a low degree 
of consistency in general structure across multiple neurons. 
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was used to cut out a 3x3 grid of squares.  Each square was 3 mm x 3mm and separated by 1 
mm.  After the stamp masks were cut by the laser, they underwent a 3x cycle of rinsing and 
sonicating in 90% Ethanol to remove any debris left over and to sterilize for cell culture.  
Following sterilization, the stamp masks were inked with an adhesive chemical composition of 
50 μM Laminin reconstituted in .1% Poly-L-Lysine for 1 hour.  The stamp masks were then 
dried and placed on clean glass coverslips sterilized by UVO treatment.  PLL was then 
immediately added to the wells and incubated for an additional hour.  The PLL was removed and 
rinsed 3x with sterile Phosphate Buffered Saline.  Neurons from primary harvest of Sprague 
Dawley rat cortices were seeded at a concentration of 200k cells per cm2.  See section on primary 
neuronal culture harvest for full protocol.  After 1 hour, the stamp masks were removed, 
coverslips were rinsed 2x and then returned to the incubator.  
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3.3.3 Testing the Effectiveness of the Stamp Mask Technique. 
The stamp mask procedure utilized the 1 mm barrier regions (Fig. 3-13A) to both isolate 
a region of the coverslip from cell bodies and to lay down chemical cues to promote axonal 
growth.  Immediately following seeding and removal of the stamp mask, the isolated region was 
easily visible (Fig. 3-13B).  After 14-21 DIV, immunolabeling of neuronal cultures indicated that 
only axons (indicated with Tau) grew into the isolated region whereas both dendrites (MAP2) 
and glial cells (GFAP) were confined to the seeding well regions.  Therefore, any process found 
 
Figure 3-12: Construction of Stamp Mask. 
The stamp mask technique utilizes a combination of mask seeding and microcontact printing, also 
referred to as ‘stamping’ to produce anisotropic neuronal cultures with regions of isolated axons.  The 
stamp mask is constructed from a PDMS disk that contains microgrooves on one side.  A versa laser is 
used to cut multiple squares out of the disk to create wells for seeding.  Prior to seeding, the mask is 
inked with adhesive proteins, dried, and placed onto a clean glass coverslip.  Neurons are seeded into 
the wells and allowed to adhere to the glass surface.  The stamp mask is subsequently removed leaving 
adhered cell bodies and axon growth cues on the surface.  Over 7-14 days, neurons extend axons onto 
the adhesive ECM proteins creating regions of isolated axons.   
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in the central region could be identified as an axon without the use of immunolabeling 
procedures.   
 In addition to generating regions of isolated axons, we were able to modify the degree of 
axonal anisotropy by changing the geometric cues of the microcontact printed area.  Whereas the 
15 x 15 μm lines indicated previously produced nicely aligned, separated axons, removing these 
features allowed the printing of an isotropic adhesive surface resulting in an isolated region of 
non-aligned axons (Fig. 3-14).  Although we did not fully characterize the effects of changing 
the stamp mask features, it was clear that modifying the feature properties such as line width as 
well as the distance between wells affected the general alignment of the isolated axonal region.  
Furthermore, modifying the density of neuronal somas seeded in the well regions also influenced 
the density of axonal processes found in the isolated axon regions.  For all future injury studies, 
we found the optimal parameters to be 15x 15 µm lines with well regions spaced 1.5 mm apart 
and a seeding density of 200k cells per cm2.  
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Figure 3-14: Isotropic and Anisotropic Axon Only Regions. 
Depending on the microgroove features imprinted onto the PDMS, the isolated axon region can 
exhibit varying degrees of aligned axons. Using only a smooth surface, isotropic axons are grown in 
the central region.  Using uCP lines of 15 µm width with 15 µm spacing results in highly aligned, 
anisotropic axons.  
Calcein 3 mm 20 μm 15 μm
Isotropic µCP 15x15 µm lines
 
Figure 3-13: Isolation of Axon Rich Region Using Stamp Mask. 
Example images from the stamp mask protocol indicate the microcontact printed (ucp) lines on one 
surface of the stamp mask as well as the separation of cell seeding regions (upper left).  After seeding, 
neuronal cell bodies are separated by a region of uCP adhesive proteins that promotes axonal growth 
(lower left).  After 7-14 days in culture, immunostaining reveals the outgrowth of only axons (upper 
right) into the center region with dendrites unable to extend across the gap (lower right). 
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3.4 Development of an Automated Method for Quantifying Axonal Injury in vitro 
3.4.1 Design of Automated Analysis of Axonal Morphology.    
A major difficulty in studying axonal injury in vitro arises in the proper identification of 
injured axons.  Since the only definitive pathology is a morphological change of the axon, the 
obvious analysis technique is microscopy.  However, distinguishing a normal axon from an 
injured axon is not obvious, and moreover, distinguishing the severity of an injured axon is 
completely unclear.  At what point a normal change in axon diameter becomes pathological is 
left to the individual researcher to determine and to attempt to keep consistent throughout the 
analysis.   
In order to address this shortcoming, we sought to develop an automated analysis strategy 
in which (1) no manual identification of morphology is necessary and (2) no preconceived 
characteristics of axon focal swellings are defined. 
 
3.4.2 Building the Software Package for Automated Analysis of Axon Morphology  
We developed a protocol combining semi-automated imaging of live neuronal cultures 
with post image analysis in both ImageJ and Matlab to identify and quantitatively measure the 
extent of axonal injury in vitro.  The process begins with live imaging of neurons that are 
fluorescently tagged in order to provide sufficient signal to noise ratio as to identify axon 
segments (Fig. 3-15A).  We utilized Calcein to label our neurons as this provided a fluorescent 
molecule that is confined to the interior of the cell membrane yet is able to diffuse freely 
throughout the cell volume without attaching to specific structures.  Calcein is typically used in 
live/dead stains to indicate viable cells and therefore provides the additional benefit of verifying 
the viability of the axons we are imaging.  Following time lapse imaging of a field of view 
(FOV) within the isolated axon regions of our neuronal cultures, the image series undergoes a 
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sequence of post processing using custom scripts and image processing techniques written in 
both ImageJ and Matlab software packages.  ImageJ scripts are responsible for skeletonizing the 
first image of each sequence to provide a mask that indicates the coordinate locations of axons 
within the particular FOV (Fig. 3-15B).  Skeletonizing is accomplished through a series of image 
filtering and morphological analysis that can be found in the attached code.  After skeletonizing, 
the image sequence is passed to Matlab where the morphological properties of the axon are 
measured at each time point.  This process begins with the measurement of the axon cross 
section at each point along each axon at each time point (Fig. 3-15C).  The cross section provides 
the best estimate of the axon width at a particular point.  Multiple options exist for specifying 
how the cross section is measured.  For future injury experiments, and absolute threshold was set 
where the cross section was measured as the full width at a pixel intensity value of 25 within an 
8 bit image.  Initial images are background subtracted such that the absolute value provides a 
constant SNR above background levels of fluorescence.  After the width is measured at each 
point along an axon segment (Fig. 3-15D), the width values are inserted into a matrix (Fig. 3-
15E) that provides a quantitative depiction of the morphology of that particular axon in time.  
The morphology matrix is used in subsequent analysis to identify the presence of injury.         
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3.4.3 Testing the Automated Analysis of Axon Morphology. 
Initial testing to ensure the effectiveness of our custom analysis software was performed on fake 
axon segments drawn in adobe illustrator that will be referred to as pseudo axons.  The 
importance of this verification step is twofold.  First, the accuracy of the automated measurement 
of cross sections was verified.  Second, the ability to resolve axonal swellings given the optical 
resolution of our experimental setup was verified.  To do so, multiple axon segments were drawn 
with varying sizes and number of focal swellings (Fig. 3-16A).  These segments were converted 
 
Figure 3-15: Summary of AMA Protocol. 
(A) Automated analysis of axon morphology begins with skeletonizing an entire field of view (FOV) 
that has been imaged throughout the course of an experiment.  Skeletonizing results in a 1 pixel wide 
trace of the axons.  (B) After tracing, axon width is measured at each discrete point along the axon.  
The width is quantified by measuring the distance between an absolute threshold of pixel intensity, set 
to 30 in an 8 bit image for this analysis.  (C) Width measurements are made along the entire axon 
segment and for all axons within a FOV.  (D) Each axon width measurement is made at multiple time 
points allowing the generation of a map of axon widths in time.  This matrix is referred to as the axon 
morphology map. 
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to tiff images with resolution that matched the output from our imaging system, meaning that the 
number of pixels that defined a typical real axon segment was also imposed onto the fake axon 
segments.  Subsequent analysis of the pseudo axons was performed and produced a morphology 
matrix that indicated accurate measurement of both smooth axon segments as well as individual 
focal swellings (Fig. 3-16B).      
 After verifying the accuracy of the measurements, it was necessary to define an injury 
metric that converted the morphology matrix data into a numerical indicator for comparison 
across conditions.  Given that the morphology matrix contains a wealth of information, multiple 
single parameters could potentially be calculated.  In order to maximize robustness we sought a 
 
Figure 3-16: Verifying Measurement Accuracy on Pseudo Axon Images. 
Verification of the accuracy of axon width measurements was performed using a set of pseudo axons 
that were drawn in adobe illustrator with specific, known widths and focal swelling sizes.  (A) Fake 
axons were constructed to contain multiple width measurements and amounts of focal swellings.  (B) 
Automated analysis of the pseudo axons revealed accurate measurement of axon widths and accurate 
detection of the multiple degrees of axonal swelling. 
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simple metric that captured the amount of change in axon morphology that occurred in time.  We 
decided on a metric termed the sum of the width gradient squared (SGS) to condense the 
morphology matrix into a single parameter (Fig. 3-17A).  The essence of the metric is that it 
captures any change in morphology by first taking the geometrical derivative (change of width in 
space) and then captures the amount of change by summing up the square of this value along the 
entire segment.  It was necessary to control for differences in axon segment lengths, which was 
accomplished by dividing by the total length of the segment to produce a unit less parameter that 
effectively indicates the amount of change of the axon width per length of axon.  The usefulness 
of condensing the information of the morphology matrix into a single parameter can be indicated 
using example segments (Fig. 3-17B).  An initially smooth segment can be quantified by a 
specific SGS that changes at a later time point once axon swellings appear.  By normalizing the 
SGS to the earlier or initial time points, a relative changes in SGS (NSGS) is calculated and can 
be compared across axon segments. 
The automated analysis of axon morphology combined with the NSGS metric was tested 
on multiple FOV to verify robustness in detecting axon segments and quantifying axon 
morphology characteristics.  An example  FOV illustrates how multiple axons (Fig. 3-18A) are 
segmented (Fig. 3-18B) and subsequently measured to produce quantitative descriptions of 
length and width measures (Fig. 3-18C,D).  
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Figure 3-17: Testing Injury Metric on Pseudo Axons. 
(A) In order to quantify the axon morphology using a single metric, we developed a score based on the 
sum of the square of the gradient of the axon width, termed SGS. This metric captures the relative 
amount of change in axon width along the length of the axon.  In order to compare the SGS metric in 
time, it is normalized to an initial point, typically the first time point, to generate a normalized SGS 
metric or NSGS.  (B) Analysis of an example segment illustrates how the SGS metric quantifies two 
segments with varying amounts of focal swelling and how the NSGS metric can quantify the relative 
amount of change within that segment in time.     
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 Individual segments exhibiting focal swellings can be identified and isolated for 
additional analysis or for demonstration purposes.  Figure 3-19 illustrates a specific segment that 
exhibited axonal swelling.  The morphology change is noticeable in the binary image (Fig. 3-
19A) and is further identified in the traces of axon width (Fig. 3-19B) and width gradient (Fig. 3-
19C).  In order to determine the effectiveness of the NSGS parameter in detecting the 
morphology change, we plotted the temporal progression that indicated an increase around 30 
minutes post MTC induced injury (Fig. 3-19D).  Future axonal injury studies will use the 
automated axon morphology analysis strategy combined with additional statistical analysis to 
pursue the relevant scientific hypothesis.   
 
 
Figure 3-18: AMA Analysis on Example FOV. 
Extending the AMA analysis beyond single segments to an entire population is necessary to quantify 
the amount of axonal injury within a population.  A single field of view can be divided into multiple 
axon segments of constrained length, each of which has a range of potential axon widths. 
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3.5 Discussion 
A large effort was placed in developing this tool set for the sole purpose of addressing our 
research question.  While some of the tools represent novel developments of technologies (e.g. 
AMA analysis) others consist of a combination or adaptation of existing technologies with novel 
purpose (e.g. MTC as an injury model, stamp masks for producing isolated axons).  Effort was 
made in writing this dissertation to provide necessary reference to the pre-existing techniques 
and technology and to clearly indicate where the ‘novelty’ was in adaptation or combination as 
opposed to conception.   
The primary advancement and contribution of this chapter was in the development of a 
complete package aimed at advancing the ability of current in vitro TBI studies to better address 
questions of mechanosensitivity of axons.  We focused on adapting techniques and strategies 
from relevant fields that could be applied to our research interests and developing new strategies 
 
Figure 3-19: NSGS Measurement of Axon Segments. 
Each axon segment from a single field of view is analyzed individually in time.  Its distinct (A) 
threshold morphology, (B) measured width, (C) and gradient of the width is calculated.  Following 
this analysis, multiple segments can be compared across conditions generating (D) a data set with 
multiple independent variables. 
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and techniques when no existing ones could be found.  In particular, a wealth of relevant 
information, tools, and techniques was found amongst the traditional field of mechanobiology.  
Although this field is by no means new, there is relatively little crossover between it and in vitro 
TBI.  Mechanobiology tends to focus on the basic principles of mechanosensitivity of cells at the 
cell and sub-cellular level.  The tendency is to focus on cells that experience more obvious 
mechanical interactions such as muscle or endothelial cells, yet many of the structures and 
processes are ubiquitous and likely relevant to mature neurons as well.  It is our intention that by 
borrowing from existing knowledge within the field of mechanobiology, we can make more 
timely advances in understanding how mature neurons respond to physical forces during TBI.  
By developing a package of technologies including the injury model, in vitro tissue substrates, 
and analysis methodology that is amenable to elucidating mechanosensitive structures within the 
axon, this chapter has served as the foundation for our future TBI studies focused on elucidating 
mechanosensitive processes related to cell-ECM interactions.       
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4 Axonal Injury Depends on the Extracellular Matrix through which 
Trauma Forces are Directed 
4.1 Introduction 
  The non-uniform distribution of axonal injury within the brain previously described in 
Chapter 1 supports the question of why certain brain regions are more or less susceptible to 
Traumatic Brain Injury (TBI). Despite previous attempts to explain vulnerabilities from a 
mechanical standpoint (also outlined in Chapter 1), certain aspects of TBI pathology appear to 
depend on factors other than purely mechanics and mechanical properties.  One particular 
example is the distribution of Diffuse Axonal Injury (DAI) that is typically described as a multi 
focal, non-uniform distribution observed diffusely throughout the brain [34].  These injury 
patterns include multiple isolated regions in which injured neurons are found immediately 
adjacent to uninjured neurons.  We hypothesized that the distribution of injured neurons 
interspersed with uninjured neurons may be due to factors in the local cellular microenvironment 
that affect the susceptibility of a neuron or axon to local forces.  Given the implication of 
mechanochemical coupling in axonal injury from Chapter 2, we reasoned that the local 
extracellular matrix (ECM) composition surrounding a neuron may influence its 
mechanochemical coupling and thus its susceptibility to trauma. 
 Despite the high density of cellular components in the brain, the extracellular space 
constitutes approximately one-fifth of its total volume [273] and is comprised of diverse ECM 
proteins including glycosaminoglycans (GAG), proteoglycans (PG), and glycoproteins (GP). 
Hyaluronic Acid (HA), Chondroitin Sulfate Proteoglycans (CSPGs), Tenascin-R (TnR), and 
Link Proteins together form the primary extracellular scaffolding structure within the brain.  
Although an extensive analysis of the regional expression levels of individual ECM molecules 
has only been performed in the mouse brain [64], several reports support the existence of 
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differential regional expression in multiple species including opossum [44], hedgehog [204], and 
humans [43].  Table 2 summarizes the extent of known ECM localization reported in the 
literature for both non-human and human brains, indicating that while less is known about the 
human distribution, brain ECM is ubiquitously expressed and differentially distributed.   
The most prevalent component of the brain’s ECM is HA, a GAG formed by a linear 
polymer of disaccharides [195]. HA is secreted into the extracellular space by membrane bound 
enzymes called Hyaluronan synthases (HAS) [278] that may localize to neurons [50].  CSPGs 
are comprised of a protein core to which variable numbers of linear, unbranched chondroitin 
sulfate GAG chains are covalently bonded.  Aggrecan, brevican, neurocan, and versican are 
prominent CSPGs, commonly referred to as lecticans, that vary in size between ~90kDa 
(Brevican) up to ~400kDa (versican) [244,320].  The cellular source of CSPGs is controversial, 
but likely includes both neurons and glial cells [50].  Tenascin-R is a trimeric, modular GP found 
primarily in the nervous system [279] and has been shown to be synthesized by both neurons and 
glial cells [50].  Link proteins are a group of small ~38-43 kDa proteins shown to be synthesized 
by both neurons and glial cells [50].  Additional proteoglycans, such as heparin sulfate 
proteoglycans (HSPGs), and glycoproteins, such as reelin, also exist in the brain ECM, 
contributing to its structural and functional diversity.  
Unique sub-cellular components form structures within the brain that contribute to the 
mechanical integrity of the cell.  Furthermore, distinct compositions of these components exist 
within the brain, forming specific cellular microenvironments that serve varying functions.   
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4.1.1 Distinct Cellular Microenvironments Contain Sub-cellular Structures that 
Influence Physiological Processes in the Brain   
The diversity of cell types and ECM within the brain has led to distinct microenvironments 
in which specific structures comprised of these components influence physiological processes.  
Organized ECM structures called Perineuronal Nets (PNNs) (Fig. 4-1A) localize to the soma and 
perisomatic extensions of neurons in multiple brain regions [37,205,227,50,191,43,99].  PNNs 
preferentially ensheath highly active neurons [205], suggesting they may function as a buffer for 
cations important in action potential generation [124].  PNNs may also limit plasticity as they are 
upregulated at the end of critical periods in development [227,49] and stabilize dendritic spine 
Table 2: Regional ECM Expression in the Developed CNS 
 
 Non-Human Human Reference (N,H) 
Cerebral Hemisphere 
Cerebral Cortex HA, A, B, N, V, P, LP, Tn-
R, Tn-C, R, HSPG 
HA, CSPG, A, B [320,66,67,41,16,81,101,20
2,64], 
[203,42,251,312,287,225,1
71] 
Amygdala HA, A, N, B, V, P, LP, Tn-
R, Tn-C, L, HSPG 
CSPG [193,197,230,202,288,27,1
92,101,93,136,65,184,64], 
[225,203,224] 
Hippocampus HA, A, N, B, V, P, LP, Tn-
R, Tn-C, R, HSPG 
HA, A, B, R [320,16,81,101,202,288,93,
136,65,184,252,26,28,27,6
4], [312,171,98] 
 
Thalamus HA, A, N, B, V, P, LP, Tn-
R, Tn-C, HSPG 
HA, CSPG, A [202,27,288,320,40,64], 
[203,170]  
Basal Ganglia  HA, CSPG,  A, HSPG CSPG [43,312,64] 
Hypothalamus HA, CSPG, N, V, LP, Tn-
C, HSPG 
CSPG [193,197,230,64], [203] 
Cerebellum HA, A, B, LP, Tn-C, R, 
HSPG 
HA [310,237,202,16,309,252,1
36,65,184,64], [312] 
Brainstem HA, A, N, B, V, P, LP, Tn-
R, Tn-C, HSPG 
CSPG [202,27,288,320,40,64], 
[249] 
Spinal Cord    
Gray Matter HA, CSPG, A, HSPG HA, Tn-R, A, B, N, 
V 
[64], [142,64] 
White Matter HA, CSPG, A, HSPG HA, Tn-R [64], [142,64] 
HA: Hyaluronan, CSPG: Chondroitin Sulfate Proteoglycan, A: Aggrecan, B: Brevican, N: Neurocan, V: Versican, HSPG: 
Heparin Sulfate Proteoglycan, LP: Link protein, TnC: Tenascin-C, TnR: Tenascin-R, R: Reelin 
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formation [162] potentially by influencing binding of CAMs.  Distinct ECM structures also 
surround synapses, influencing both development and plasticity associated remodeling of these 
structures (Fig. 4-1B) [323,78].  ECM molecules at the synapse have been shown to both 
promote and inhibit plasticity, as well as influence the clustering of postsynaptic receptors by 
limiting diffusion in the membrane [96].  This is accomplished through interactions with CAMs 
such as integrins and NCAMs [79,71] and transmembrane channels such as voltage dependent 
calcium channels [207,157].  Traditional adhesions like integrins [56] and cadherins [284] as 
well as neural specific adhesions like Neuroligin, Neurexin [271] and SynCAM [30,109] 
influence synaptic connectivity through signaling pathways that directly influence synapse 
formation and plasticity by regulating cytoskeleton organization [79,80].  Specific CAMs such as 
Caspr2, contactin, and NrCAM are also important in organizing the myelin structure that forms 
around axons in the brain [111,229].  Organized ECM scaffolds occupy the space between 
myelin wrappings, called Nodes of Ranvier (Fig. 4-1C) [19], and may promote clustering of Na+ 
channels that is necessary for signal propagation in the axon [272].  Finally, an organized ECM 
scaffold exists around the vasculature in the brain and influences cellular attachment and 
organization of the multicellular vascular structures (Fig. 4-1D).  ECM comprised of collagen, 
laminin, and HSPGs surrounds the inner layer of endothelial cells and also engulfs pericytes 
forming a structure referred to as the tunica intima [113].  In larger vessels, such as arteries and 
arterioles, a middle layer referred to as the tunica media is formed by multiple layers of ECM 
and smooth muscle cells as well as an outer layer called the tunica adventitia [135].  The external 
layer of ECM promotes adhesion of neural cells, such as terminal nerve fibers and astrocyte 
endfeet, which contribute to numerous vasculature functions including regulating cerebral blood 
flow and forming the blood brain barrier [1].  Thus, distinct cellular microenvironments 
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Figure 4-1: Unique cellular microenvironments exist within the brain. 
(A) The Perineuronal Net (PNN) is formed by extracellular matrix (ECM) and engulfs the soma and 
proximal dendrites of neurons.  Neuronal structure may be influenced by the PNN through interactions 
with cell adhesion molecules (CAMs), which together regulate neuronal connectivity.  (B) Synapses 
are formed between neuronal axons and dendrites but are also influenced by supporting ECM and 
astrocytes.  These components are structurally connected through binding of CAMs that influence 
formation and remodeling of the synapse.  (C) Myelinated axons consist of multiple layers of 
oligodendroctye processes that wrap around the axon with distinct spacing referred to as Nodes of 
Ranvier (NOR).  ECM within the NOR may influence the clustering of ion channels important for 
axonal signal propagation.  (D) The extensive vasculature within the brain varies in size from larger 
arteries and veins down to small capillaries, each of which has a unique structure. ECM comprised of 
collagen, laminin, and HSPGs surround the inner layer of endothelial cells (En) and also engulf 
pericytes (P), forming a basement membrane (BM) for cell attachment.  In larger vessels, such as 
arteries and arterioles, a middle layer referred to as the tunica media is formed by multiple layers of 
ECM and smooth muscle cells (SM) as well as an outer layer called the tunica adventitia (TA).  The 
external layer of ECM promotes adhesion of neural cells, such as terminal nerve fibers and astrocyte 
endfeet (A), which contribute to numerous vasculature functions including regulating cerebral blood 
flow and the blood brain barrier. 
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influence both cellular structures and functions important to normal brain physiology. Although 
critical functions of brain specific CAMs and ECM structures are beginning to emerge, their 
potential influence in mechanotransduction mechanisms remains relatively unexplored.  
4.1.2 Brain Extracellular Matrix and CAM Expression in Axons 
Unlike other tissue types such as muscle, an understanding of the structure and 
composition of the ECM directly adjacent to neural cells is not clear.  Although a general 
understanding of components and to some extent localization has been reported, these remain 
insufficient to correlate with the location of TBI pathology.  We previously hypothesized that 
cell-ECM linkages may direct injury forces through mechanosensitive cellular structures and 
showed that the extent of focal adhesions correlated with injury sensitivity.  Different ECM 
proteins can interact with different cell surface receptors and CAMs and therefore present a 
potential to elicit varying severities of injury.     
Integrins are expressed heterogeneously throughout the brain and have been shown to be 
differentially expressed in the adult rat brain [54,226].  Integrins are highly expressed in synaptic 
regions [243,213] and can modulate synaptic plasticity by regulating ion channel currents 
[173,255,300].  In the developing nervous system, integrins are involved in dendrite and axon 
outgrowth [242,277,128,248] and guide synaptogenesis [255,300], and in mature neurons, they 
influence remodeling of dendritic spines [255,301].  Their ability to modify Ca2+ handling and to 
modulate synaptic strength has also been linked to stabilizing long term memory potentiation 
[264], suggesting that integrins may be key players in memory and learning [300,54]. 
Beyond implications in normal functions, the potential for integrins to contribute to the 
pathophysiology associated with TBI remains unexplored.  Previously, TBI related forces at the 
cellular level have been linked to the cell membrane as well as the underlying cell cytoskeleton.  
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However, no specific conduit for propagating these forces has been proposed or explored.  Given 
the large body of research that indicates CAMs serve as a mechanical linkage between the 
extracellular space across the membrane to the cytoskeleton, we reasoned that they may serve as 
that conduit. 
In this chapter, we aim to determine if directing injury forces through different components 
of brain ECM-cell linkages elicit differential injury levels.  In doing so, we can answer the 
question of whether the ECM composition of neuronal microenvironments can explain the 
differences in injury susceptibility of certain neurons and thus clarify the multi-focal distribution 
axonal injury observed in DAI.      
 
 
4.2 Results 
4.2.1 ECM Expression in the Brain 
Reports of brain ECM immunolabeling are rare and none are sufficient to provide a 
complete understanding of what ECM are in closest proximity to the axon.  In fact, the most 
quantitative analysis was performed in the mouse with labeling of only 4 components and a 
semi-quantitative scoring method [64].  Therefore, we performed a series of immunolabeling 
studies in which we attempted to immunostain the predominant brain ECM components in both 
tissue sections from adult rat (Fig. 4-2A,B)  as well as in mature neuronal cultures at DIV 14-21 
(Fig. 4-2C,D).  We successfully labeled multiple classes of brain ECM in both tissue and cell 
culture verifying that components such as TnR, CSPGS, and HA are present.  We also observed 
varying staining patterns that are typically characterized by sparsely labeled neurons with 
increased density near the soma and perisomatic extensions.  These results are consistent with 
those previously published in the literature.  We attempted to further characterize the distribution 
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of specific components using colocalization, especially in regions nearest the axon.  
Unfortunately, the large degree of variability in staining patterns and difficulty in obtaining 
multiple antibodies resulted in the inability to quantitatively measure which components are 
predominantly localized near the axon.  Instead of pursing a detailed immunolabeling study of 
brain tissue, we decided to utilize a range of brain ECM molecules in the subsequent axonal 
injury studies.    
 
 
Figure 4-2: Immunolabeling of Brain ECM Molecules. 
Adult rat tissue sections indicate ECM distribution of (A) Aggrecan and the dual localization of (B) 
Aggrecan and Tenascin-R.  Mature neuronal culture DIV 14-21 indicate the presence of (C) Aggrecan 
and (D) Brevican near neurons (indicated by β3 Tubulin).  All scale bars indicate 100 µm. 
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4.2.2 Brain ECM Dependent Axonal Injury Rates 
Since multiple forms of ECM exist in the brain, we sought to determine the effect on 
axonal injury susceptibility when trauma forces are directed through a specific type of ECM.  To 
do so, we utilized the Magnetic Twisting Cytometry (MTC) model of axonal injury wherein the 
microbeads were coated with a specific type of ECM (Fig. 4-3A).  Coating of microbeads with 
each type of brain ECM was verified by fluorescently tagging the molecules prior to binding.  
Subsequently, the microbeads were imaged (Fig. 4-3B) and fluorescence levels were compared 
to that of stock beads to ensure fluorescence was due to the tagged ECM (Fig. 4-3C).     
In order to determine if the brain ECM microbead coating affected axonal injury 
susceptibility, we performed multiple injury studies using either Bovine Serum Albumen (BSA), 
Acetylated Low Density Lipoprotein (LDL), FN, TnR, Brev, Agg, or HA coated beads.  All 
microbeads were coated with BSA following their respective ECM coatings.  Microbeads coated 
solely with BSA served as a control to account for potential interactions between the microbead 
surface and cell surface receptors.  LDL coated beads served as another control condition as LDL 
is known to bind to a cell membrane receptor that influences metabolism but that does not serve 
as a CAM, and therefore represents non-adhesion binding proteins.  The remaining ECM types 
are all found in the adult brain and represent multiple classes of brain ECM.       
 Axonal injury experiments consisted of a precise protocol in which the only variation was 
due to the microbead coating.  Experiments began by seeding coated microbeads onto a neuronal 
culture coverslip at a concentration that was verified to ensure maximum coverage of the 
coverslip.  This number was initially estimated based on the coverslip area and experimentally 
verified to be ~5 million microbeads.  The experimental protocol is illustrated in Figure 4-4.    
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 Following injury experiments, a large data set was generated that was characterized by 
multiple independent variables.  In order to properly determine the effects attributed to bead 
coating, we had to also account for variability due to additional factors such as presence of the 
bead, time, and axon width.  To do so, we initially pooled the entire data set and determined if 
there were significant differences in any of these main effects.  We found that adhering ECM-
 
Figure 4-4: Axonal Injury Experimental Protocol. 
A precise protocol was followed to induce axonal injury.  Microbeads were initially seeded at a 
density of ~5 million beads per coverslip or ~65 thousand per mm2.  Following seeding, neurons 
underwent a precisely timed sequence of bead magnetization, neuronal labeling, and imaging.  The 
protocol produced a time series consisting of 15 minutes of pre-twist data followed by 60 minutes of 
post-twist data.   
 
 
Figure 4-3: Labeled ECM Coated Microbeads. 
(A) Schematic illustration indicates how MTC can be used to control the local ECM through which 
forces are directed to neurons.  (B) Verification of ECM coating on the microbeads was accomplished 
using immunofluorescence which indicated (C) a significant increase in fluorescence levels compared 
to control beads when fluorescently tagged proteins were adhered to the microbead surface. All bars 
SEM for all panels, * p < 0.05.   
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coated microbeads (without twisting) was not sufficient to cause changes in NSGS levels (Fig. 4-
5A).  However, when the beads were twisted, we did find a significant increase in the NSGS 
value indicating that microbead twisting did induce axonal injury.  Next, we identified a 
significant difference in the time course of axons subjected to bead twist compared to those that 
experienced no twist (Fig. 4-5B).  There was a small increase in the NSGS value for the no twist 
condition in time, however, this can likely be attributed to normal fluctuations in axon 
morphology.  Finally, we found that the average initial width of the axon segment also affected 
its NSGS level.  Significant differences were found between the no twist and twist conditions in 
axons whose initial average width was between 1.25 and 2.25 µm but not in those with widths 
between 2.25 and 2.75 µm (Fig. 4-5C). Therefore, variations in the NSGS level were found to 
depend upon bead twist, time, and initial axon width.  
After identifying multiple sources of variance in our data set, we then sought to address 
our primary hypothesis.  This is consistent with asking whether there are significant differences 
in NSGS values that can be attributed to microbead ECM coating, taking into consideration bead 
twist, time, and initial axon width.  We found that when variance due to time and axon width was 
accounted for, there was no significant difference between ECM coatings when microbeads were 
adhered but not twisted (Fig. 4-5D).  When microbeads were twisted, we did observe a 
significant difference in NSGS levels attributed to ECM coating (Fig. 4-5E).  Specifically, we 
found no difference between control microbeads coated only with BSA or LDL indicating that 
directing forces either non-specifically or through non-adhesion receptors did not increase injury 
levels.  FN, TnR, and Brev coated microbeads all exhibited increased injury levels, significantly 
greater than the other bead coatings, with TnR eliciting the largest degree of injury.  Neither Agg 
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nor HA coated microbeads elicited injury levels significantly above control or non-adhesion 
coatings.  Taken together, these results suggest that the local ECM composition through which 
forces are directed to neurons can influence the susceptibility to injury.  Furthermore, whether 
the specific ECM component exhibits affinity for CAMs may be an important factor in 
determining how injurious the localized forces are to the neuron. 
 
Figure 4-5: Brain ECM Dependent Axonal Injury. 
The extent of axonal injury induced by MTC was compared across multiple independent variables.  
(A) Initial tests ensured that there was no statistical difference in samples subjected only to the 
presence of adhered microbeads.  However, when those microbeads were twisted, injury levels did 
increase significantly.  (B) Injury levels were also shown to depend upon time following the bead 
twist.  An average onset time of injury can be observed around 10 minutes post twist.  (C) Injury 
levels were also shown to depend upon the average initial axon width.  These results indicate that 
axons with lower initial widths are more susceptible to injury compared to their larger counterparts.  
After controlling for the multiple conditions that contribute to variation in the axonal injury data set, 
we identified (D) no injury dependency on bead coating in samples that were not subjected to bead 
twist, however (E) we did detect a dependency in samples that were subjected to bead twist indicating 
that certain brain ECM coatings resulted in higher levels of injury. Statistics analyzed using multi-way 
ANOVA followed by Post hoc Bonferroni pairwise comparison (α=.05). All bars SEM.     
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4.2.3 Integrin Dependent Axonal Injury Rates 
In order to determine if directing forces through integrins is sufficient to cause axonal 
injury, we again utilized the MTC model of axonal injury (Fig. 4-6A).  Instead of attaching 
various ECMs to the microbead surface, we instead used the same chemistry to covalently attach 
integrin antibodies (Abs) for specific subunits.  We verified the existence of receptors for 
specific Abs to be used in injury experiments by immunolabeling neuronal cultures. Two 
different integrin antibodies to β1 and β3 subunits successfully labeled neurons as well as the 
axon only regions of the coverslip (Fig. 4-6B).  These results indicate that both β1 and β3 
integrin subunits are expressed in vitro  and furthermore that they localize to the axons.           
After verifying that both of the β integrin subunits were expressed in axons of our neuronal 
culture, we attempted to determine their influence on microbead binding.  Of the three brain 
ECM molecules that produced the largest injury rates in previous studies, FN is the best known 
and most widely studied as an integrin binding ECM.  To determine if FN coated microbeads are 
interacting with integrin subunits in our cultures, we performed Ab blocking experiments in 
which 1 µM of either β1 or β3 integrin Ab was incubated with the neuronal cultures prior to 
addition of microbeads.  After 30 minutes of incubation, non-adhered beads were gently 
removed by placing a permanent magnet in the solution above the coverslip surface.  The 
percentage of the coverslip area covered by axons that remained covered by adhered beads was 
compared to control samples that contained no blocking Ab.  We found that with the addition of 
either β1 or β3 antibody, the amount of bead coverage may be slightly reduced, however, the 
results contained too much variance to draw a definitive conclusion.  Future experiments such as 
these will be necessary to determine the extent of interaction between specific ECMs cell surface 
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receptors.     
 Given the shortcoming of directly measuring the effects of integrin blocking Abs on 
ECM mediated injury, we sought to measure injury levels elicited by directing injury forces 
specifically through integrins.  To do so, we utilized the MTC injury model with microbeads 
coated with antibodies to either β1 or β3 integrins. Experiments were performed as previously 
indicated.  We found that neither β1 nor β3 integrin Ab coated beads induced injury when 
microbeads were adhered but not twisted (Fig. 4-7A).  However, following microbead twist, an 
increase in NSGS levels was observed (Fig. 4-7B). β1 integrins elicited injury levels that were 
slightly elevated compared to both control and non-adhesion receptors coatings, however these 
levels were not statistically different.  We did observe statistically greater NSGS levels elicited 
by β3 integrin Ab coated microbeads.  Moreover, these injury levels were greater than both 
control and non-adhesion coatings as well as that of the β1 induced levels.  Therefore, this data 
 
Figure 4-6: Integrin Ab Staining In Axon Rich Regions. 
(A) Schematic illustration indicates that integrin binding beads will couple directly into the 
cytoskeleton whereas non-integrin binding beads will interact with cell surface receptors that do not 
couple into the cytoskeleton.  (B) Immunostaining for the presence of integrins in the axon only region 
of neuronal cultures indicates that both β1 and β3 integrins are expressed in vitro in axons.     
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indicates that directing forces through integrins is sufficient to induce axonal injury.  
Furthermore, the specific subtype of integrin receptor may influence susceptibility to injury.    
 
 
4.3 Discussion  
In this chapter, we explored the implication of focal adhesions and mechanochemical 
coupling in TBI by asking whether specific cell-ECM adhesions mediate axonal injury.  The 
composition of ECM surrounding a cell has been tied to both selective CAM binding [133] and 
differential mechanochemical coupling [250].  This indicates that the local ECM composition 
can influence not only the cell adhesions that form but also the extent of mechanosensitivity of 
the cell.  Little is known about the brain ECM composition, structure, and specific interactions 
with cell receptors.  Therefore, we chose to test the effect of directing injury forces through the 
most common components of brain ECM.  Here we showed that trauma forces directed through 
different components of the brain ECM elicit differential axonal injury levels.  This result is 
important because it indicates that susceptibility of axons to injury may depend upon the 
 
Figure 4-7: Integrin Mediated Axonal Injury. 
Axonal injury levels elicited by localizing injury forces through specific integrin subunits were 
measured.  (A) No significant differences were observed simply by binding coated microbeads to 
neurons.  (B) Injury rates elicited by β3 integrin bound microbeads were found to be significantly 
elevated following bead twist compared to control coatings, non-adhesion receptor coatings, and β1 
integrin coatings.  Statistics analyzed using multi-way ANOVA followed by Post hoc Bonferroni 
pairwise comparison (α=.05). All bars SEM.      
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composition of the cellular microenvironment.  While susceptibility to axonal injury has 
previously been tied primarily to mechanics, the potential for an extracellular biological 
influence at the sub-cellular level has not been reported.   
One important implication of an ECM dependent susceptibility to axonal injury is that it 
may provide an explanation for the diffuse injury patterns observed throughout the brain 
following TBI.  While material properties and tissue structure have been proposed to account for 
these regional vulnerabilities, differences in the sub-cellular compositions or microenvironments 
near the injured regions have not.  Mapping of the composition and distribution of brain ECM 
currently established in the literature is insufficient to correlate with brain regions that exhibit 
elevated injury levels following TBI. Therefore, future studies will be necessary to determine if 
specific compositions of cellular microenvironments may predispose specific regions to injury 
induced by traumatic forces.   
In addition to understanding where an injury may occur within the brain, these results 
provide a potential explanation of the diffuse injury patterns that is directly related to the 
mechanism of injury.  We discussed a brief overview of cellular mechanotransduction and 
highlighted some of the key players, and within this work we have focused on the primary 
components of the brain ECM.  While little evidence exists indicating which brain ECM 
components exhibit specific affinity for CAMs and which exhibit specific mechanosensitive 
characteristics, we assumed the potential for mechanochemical coupling due to the extensive 
literature base focused on integrins and ECM coupling.  Some reports have indicated specific 
binding between brain ECM components and integrins subunits (Table 3), although a 
comprehensive list is not known.     
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Due to its abundance in different tissues, Fibronectin is the best studied of the ECMs that were 
tested in our experimental model, and as such its interactions with integrins have been widely 
documented [147,72,62].  While FN may not be as predominant as HA, CSPGs, or TnR in the 
brain, its interactions with specific integrins, such as the α5β1 and αvβ3 subunits known to be 
expressed in the brain is the best established.  Interestingly, TnR is similar in structure to FN, 
although somewhat less complex [58], but its specific interactions with integrin subunits are 
much less documented.  Nevertheless, there is at least some evidence that suggests the potential 
for direct interaction with specific integrin subunits for all the primary components of the brain 
ECM in this study except for HA (summarized in Table 3).  Interestingly, FN and TnR exhibited 
some of the highest injury levels and are also the most established integrin binding ECMs.  Brev 
also exhibited elevated injury levels even though its potential for integrin binding is less 
established.  While this data certainly cannot definitively point to integrins as the 
mechanosensors, it presents a strong argument that CAMs such as integrins likely potentiate 
Table 3: Reported Integrin Binding to Brain ECM 
Microbead Coating Reported Neuronal Integrin 
Binding 
Bovine Serum Albumin (BSA) Non-specific 
Low Density Lipoprotein (LDL) Non-adhesion 
Fibronectin (FN) α5β1, αvβ3 
Tenascin-R (TnR) α5β1 
Aggrecan (Agg) β1*  (CSPG binding) 
Brevican (Brev) β1* (CSPG binding) 
Hyaluronic Acid (HA) None 
 
 
  Summarized from [228] and [307] 
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axonal injury.  Interestingly, when injury forces were directed through specific integrin subunits, 
injury levels were much lower for β1 integrins compared to FN, TnR, and Brev.  However, injury 
levels elicited by forces directed through β3 integrins did induce injury levels similar to that of 
these ECMs.  Multiple explanations may exist for these differences: (1) Differences in 
mechanical strength of ligand-receptor interactions between ECM and antibodies, (2) 
Differences in the activation state of integrins bound by antibodies as opposed to ECM, and (3) 
Differences in amount of ligand present on microbead surface between ECM and antibody.  
Therefore, future studies will be necessary to directly conclude that integrins are the 
mechanosensors as well as specifically which subunits are implicated.  However, the current 
results due indicate a likely injury mechanism by which exogenous forces are directed through 
specific ECM to mechanosensitive integrins.   
   In this chapter, we have focused on the potential for the ECM composition surrounding 
neurons to influence axonal injury levels.  Our findings suggest that variation in injury 
vulnerability at the cell and sub-cellular level may be due to differences in the ECM composition 
of the cellular microenvironment.  While the cellular microenvironment is influenced by multiple 
factors, ECM composition may be especially important in TBI due to its potential influence on 
cellular mechanosensitivity.  ECM-cell adhesions are known to be critical to maintaining 
neuronal structural integrity and therefore provide conduits for distributing mechanical force 
throughout the cell.  It is this specificity that provides the unique mechanosensitive functionality 
of CAMs and their associated intracellular proteins.  While we are limited in our current 
understanding of the exact cell-ECM linkages within the brain, our findings indicate that specific 
linkages affect vulnerability to axonal injury and likely provide an injury mechanism that is 
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linked to mechanochemical coupling that influences the neuronal response to exogenous 
mechanical force. 
 
4.4 Materials and Methods 
4.4.1 Ethics Statement 
All procedures were approved by the Harvard Animal Care and Use Committee under 
Animal Experimentation Protocol permit number 24-01.  This protocol, entitled "Harvest and 
Culture of Neural and Cardiac Tissue from Neonatal Rats and Mice for In Vitro Disease 
Models," meets the guidelines for the use of vertebrate animals in research and teaching of the 
Faculty of Arts and Sciences of Harvard University. It also follows recommendations included in 
the NIH Guide for the care and use of laboratory animals and is in accordance with existing 
Federal (9 CFR Parts 1,2&3), state and city laws and regulations governing the use of animals in 
research and teaching. 
4.4.2 Neuron Harvest and Culture 
Cortical neurons were isolated from 2-day old neonatal Sprague-Dawley rats (Charles 
River Laboratories, Boston, MA). Harvest protocol was established from Brewer et al., 2007 
[38].  Stamp mask technique (Chapter 3) was utilized to form anisotropic substrates with regions 
of isolated axons.  Neurons were cultured for 14-17 days post-harvest.   
4.4.3 Immunolabeling of Brain ECM in Tissue Slices 
Adult female Sprague-Dawley rats (Charles River Laboratories, Boston, MA) were 
euthanized using a combination of CO2 and cervical dislocation.  Brains were immediately 
extracted and placed on ice.  Coronal tissue slices at ~30 µm thick were taken sequentially using 
a custom built tissue slicer. Slices were fixed in 4% paraformaldehyde and 2.5% TritonX-100 in 
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PBS at 4oC for 24 hours.  Primary antibodies for Aggrecan, Brevican, and Tenascin-R were 
incubated at 200 ug/ml in 1% Bovine Serum Albumin (BSA)  (Jackson ImmunoResearch, West 
Grove, PA)  in PBS for 1 hour.  Secondary antibodies were subsequently incubated at 200 ug/ml 
in 1% BSA for 1 hour.  Immunolabeled tissue slices were mounted and preserved in ProLong 
Gold Antifade reagent (Invitrogen) and stored at -20oC until imaging.  Imaging was performed 
on an Olympus IX83 Platform with a Hamamatsu Spinning Disk Confocal (Olympus).         
4.4.4 Verification of Microbead Coating 
Microbead coating with various ECM was verified using immunofluorescence.  ECM was 
initially labeled with a fluorescence tag by incubation with TFM.  Unbound dye was 
subsequently removed using dye removal columns.  Labeled ECM was adhered to microbeads 
using the standard microbead coating protocol (outlined in Chapter 3).  Coated microbeads were 
imaged using an Olympus IX83 Platform with a Hamamatsu Spinning Disk Confocal (Olympus) 
and fluorescence levels were measured using the same laser intensity and exposure time for each 
bead coating.  Fluorescence levels of control coatings in which no protein was initially added 
were used to determine base line levels of fluorescence. Microbeads with fluorescence levels 
significantly greater than control beads were considered coated with ECM.       
4.4.5 Immunolabeling Axonal Integrins 
Cells were washed 3 times in PBS at 37oC and fixed for 1 minute in 4% 
paraformaldehyde at room temperature.  Cells were then washed 3 times in PBS and an initial 
blocking step using 5% Bovine Serum Albumin (Jackson ImmunoResearch, West Grove, PA) in 
PBS was performed for 1 hour at 37oC.  The blocking solution was aspirated away and the 
primary antibody solution was immediately added and incubated for 1.5 hours at room 
temperature.  The primary antibodies used were either anti-β1 integrin (1:200) or anti-β3 integrin 
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(1:200).  Primary antibodies were added to a 0.5% BSA in PBS solution.  Following primary 
staining, cells were washed 3 times, and the secondary staining solution consisting of either goat 
anti-mouse conjugated to Alexa-Fluor 488 4’, 6-diamidino-2-phenylindole (DAPI), and 488 
Phalloidin (1:200) (Invitrogen) were added to the cells for 30 minutes at room temperature.  
Samples were then washed 3 times.  ProLong Gold Antifade reagent (Invitrogen) was added to 
preserve the samples and glass coverslips are affixed using nail polish.  Prepared slides were 
stored at -20oC. Olympus IX83 Platform with a Hamamatsu Spinning Disk Confocal (Olympus).         
4.4.6 Microbead Binding to Neurons 
Following coating, microbeads were seeded at a density of ~5 million beads per coverslip 
or ~65 thousand per mm2.  This number corresponded to a saturating coating in which the 
maximum coverslip area was covered by microbeads.  Following microbead seeding, neuronal 
cultures were returned to the incubator for 30 minutes to allow the formation of adhesions 
between microbeads and the cells. 
4.4.7 Calcein Labeling of Neurons 
Neurons were fluorescently labeled using Calcein (Invitrogen).  Stock Calcein was reconstituted 
in 10% pluronic solution in DMSO (Invitrogen) at a concentration of 50 µg in 50 uL.  For 
labeling, 4 uL of Calcein solution was added to 1 mL of imaging media and incubated with the 
neurons for 2 minutes at room temperature.  Neurons were rinsed gently 3x with fresh imaging 
media followed by a 2 minute rest period and then rinsed 3x again.  Neurons were incubated at 
37oC for 30 minutes prior to imaging to allow fluorescence levels to stabilize.        
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4.4.8 Axonal Injury Experiment 
Axonal injury experiments followed a precise protocol that is outlined in Figure 4-4.  
Microbeads are initially adhered to neurons and allowed to incubate for 30 minutes.  Neurons 
were then rinsed gently 3x with imaging media.  All media except for 100 uL retained in the 
central area of the live imaging dish was removed and neurons were carefully transferred to the 
magnetizing coil while minimizing mechanical perturbation due to motion.  Microbeads were 
then magnetized by a single pulse of ~.1 T parallel to the length of the axon only region.  
Neurons were subsequently moved to the imaging chamber and 1 ml of imaging media was 
added.  After 30 minutes, neurons were labeled with Calcein.  Following another 30 minute 
period, multiple regions (5-10 fields of view were typical) were designated.  Each  region was 
imaged for 10 minutes at 5 minute intervals generating a time lapse of pre-twist images.  If 
samples were to be injured by microbead twist, they were then subjected to a single pulse ~.01 T 
oriented orthogonally to the magnetizing field.  High speed imaging at 50 FPS in brightfield 
verified rotation of microbeads.  Neurons were then imaged again every 5 minutes for 60 
minutes generating a time laps of post-twist images.  Following live imaging, time lapse images 
were subjected to post analysis. 
4.4.9 Post Processing of Axonal Injury Data 
 Axonal injury data (time lapse images) was analyzed using custom axon morphology 
analysis software developed in both ImageJ and Matlab.  This process is described in Chapter 3.     
4.4.10 Statistical Analysis 
Statistical analysis was performed in Matlab following the post processing automated 
analysis of axon morphology.  A multi way ANOVA test was initially used to determine if 
differences in mean values attributed to independent variables existed.  If so, subsequent 
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pairwise comparisons were run using post hoc Bonferroni analysis to identify differences in main 
effects.  Statistical tests were limited to 3 independent variables due to technical limitations of 
the software package.  Tests were run multiple times with different groupings of independent 
variables to test necessary comparisons.  α = .05 for all analyses.  All error bars are standard 
error of the mean.    
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5 Conclusions 
5.1 Importance of Implicating Focal Adhesions and Extracellular Matrix in 
Axonal Injury 
5.1.1 Interpretation of Results 
Current limitations in understanding diffuse brain damage associated with TBI may be a 
result of the complex interactions between mechanical forces and biological structures within the 
brain.  Previous studies aimed at identifying the cellular mechanisms underlying TBI have 
tended to focus on the non-specific application of force to tissue or cells within the brain.  In 
contrast, here we have suggested that a mechanical insult could utilize the extracellular matrix 
(ECM), cell adhesion molecules (CAMs), and the cytoskeleton as specific conduits through 
which forces are directed to mechanosensitive focal adhesions (FAs) within the intracellular 
space (Fig. 5-1).  Although the concept of mechanotransduction, a general process by which 
force is converted to chemical signaling, is by no means novel to TBI research, here we have 
focused on a specific class of cellular mechanotransduction previously unexplored in the context 
of TBI.  
Beyond transient membrane tearing, pathological mechanotransduction processes remain 
relatively unexplored in TBI.  In this dissertation, we have implicated mechanosensitive sub-
cellular structures in axonal injury by employing in vitro models designed to control the density 
of FAs through which injurious forces are delivered to neurons.  Using an in vitro uniaxial 
stretch model, we showed that modifying the FA density can influence the percentage of injured 
neurons, identified by morphological swellings similar to those observed in DAI in vivo.  This 
suggests that the neuronal adhesions to the ECM are an important factor in initiating injury.  
Since FAs serve as attachment sites for the cell, it is not surprising that they may influence 
cellular mechanical events.  However, since FAs also provide sites of mechanochemical 
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coupling, they may provide a means by which neurons ‘sense’ trauma forces associated with 
TBI.   
We showed evidence that inhibition of Rho-Associated Kinase (ROCK), a downstream 
effector of Rho-GTPases, was able to significantly reduce stretch induced injury levels.  
Activation of Rho-GTPases may initiate at the FA suggesting that these pathways may be 
activated in neurons following an acute mechanical strain.  In addition to supporting 
mechanochemical coupling at the FA as an injury mechanism, these findings are promising 
because they present a novel, potential strategy for treating axonal injury.  There are currently no 
therapeutic options for TBI and, even more troubling, there are few treatment strategies that have 
exhibited promising neuroprotective results.  On the other hand, much is understood about the 
vast signaling capabilities of the FA as well as the extensive physiological pathways they 
influence [159].  Determining if and which of these pathways play critical roles in TBI may 
identify numerous targets for pharmacological intervention.  Therefore, implicating ROCK 
signaling in axonal injury presents not only an additional drug target, but more importantly it 
provides a potential link to the wealth of knowledge within the field focusing on cellular 
mechanotransduction.        
Building on these results, we sought to determine the effects of modifying the extracellular 
conduit that localizes forces to FAs.  To do so, we directed forces through different brain ECM 
to affect the cell-ECM linkages through which neurons ‘sensed’ trauma.  Using a Magnetic 
Twisting Cytometry (MTC) injury model, we found that forces directed through Tenascin-R, 
Brevican, and Fibronectin resulted in elevated injury levels compared to Aggrecan or Hyaluronic 
Acid.  These results indicate that differences in the ECM content of the local cellular 
microenvironment may affect neuronal susceptibility to injury potentially due to the resulting 
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Figure 5-1: Injury forces may be transmitted through mechanosensitive sub-cellular structures 
that regulate cellular architecture. 
The intracellular space is mechanically coupled to the extracellular space through components such as 
the cytoskeleton, transmembrane CAMs, and ECM.  A dynamic force balance exists within cells 
whereby forces on intracellular components balance forces on extracellular components dictating 
cellular structure. Cells can respond to external mechanical cues by sensing alterations in this balance 
through mechanosensitive structures that respond by activating signaling pathways, many of which 
remodel the cytoskeleton to redistribute forces.  A mechanical insult suffered during TBI could alter 
this force balance by changing the forces distributed throughout the structural elements of the ECM, 
CAMs, and cytoskeleton.   
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differences in cell-ECM adhesions.  Interestingly, when forces were localizing through non-
specific adhesions using either bovine serum albumin or low density lipoprotein coatings, injury 
levels were low and on the same level as that induced by both Aggrecan and Hyaluronan.  
Therefore, directing forces specifically through adhesion receptors may be an important factor in 
initiating axonal injury, potentially because only these adhesions exhibit mechanochemical 
coupling.   
To further implicate the importance of forces directed through cell-ECM adhesions, we 
measured injury levels elicited by localizing forces through integrins.  We again utilized the 
MTC injury model to determine that directing forces though β integrins, specifically β1 and β3 
subunits, was sufficient to induce axonal injury.  These results indicate that directing injury 
forces specifically through CAMs such as integrins may be a predominant component of axonal 
injury and support the implication of FAs in axonal injury.  Furthermore, forces directed through 
β3 subunits resulted in elevated injury levels compared to forces directed through β1 subunits.  
This result suggests that the subtype of integrin may influence vulnerability to injury potentially 
by influencing the extent of mechanochemical coupling that occurs at the adhesion.  Taken 
together, these findings are important because for the first time, they implicate a family of known 
mechanosensitive sub-cellular structures in TBI.   
5.1.2 What Evidence Supports Cellular Mechanotransduction in TBI  
Several previous reports support the implication of cellular mechanotransduction events in 
TBI.  A rapid deformation of 3D collagen gels resulted in a reduction in embedded neuronal 
viability when collagen concentration was increased, suggesting a potential influence of cell-
matrix interactions on injury [69].  The actin cytoskeleton and its regulatory pathways have also 
been implicated in axon degeneration by reports showing intrinsic activation of Rho signaling 
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pathways in response to trauma in the optic nerve, increased localization of RhoA with F-actin 
rich swellings in primary hippocampal neurons, and upregulation of RhoA in both rats subjected 
to fluid percussion brain injury and in stretch injured organotypic hippocampal slices 
[100,75,82].  Cytoskeleton and membrane associated proteins such as integrins have been 
previously hypothesized to influence the axonal morphology associated with DAI in peripheral 
nerve fibers as well [216].  Evidence also suggests neurite retraction exhibits a strain dependent 
response that is regulated by stretch sensitive channel activity [95], and mechanically initiated 
sodium influx has been shown to occur in neurons subjected to rapid stretch in vitro [305].  
Interestingly, integrins have been linked to these stretch activated channels in sensory neurons 
and other cell types [174,70].  Therefore, evidence for the involvement of mechanotransduction 
events beyond transient membrane rupture is emerging, however, future studies are necessary to 
elucidate and link these components of injury.       
In addition to the immediate contribution of mechanotransduction, there is evidence that 
suggests possible long term cellular changes initiated by mechanical events.  Alterations in 
protein expression have been observed in neurons exposed to a single rapid stretch in which 
sodium channel expression was greatly increased 24 hours following trauma [315].  This 
increase in channel expression was linked to an increased susceptibility to subsequent injury.  In 
our lab, we previously showed that vascular smooth muscle cells subjected to a single, rapid 
stretch exhibited altered calcium handling followed by a phenotypic switch to either contractile 
or synthetic states depending upon the magnitude of stretch [7]. Furthermore, the increased 
contractility was mitigated by immediate treatment with a ROCK inhibitor, providing additional 
evidence for the involvement of Rho-signaling following stretch induced injury.  In addition to 
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providing a potential explanation for the vasospasm observed following blast TBI, these studies 
illustrate the potential long term effects of cellular remodeling due to a single mechanical event.   
The major importance of this research lies in the potential identification of mechanical 
activation of specific signaling pathways, termed mechanochemical coupling, that likely 
accompany the initial trauma.  Since much of the morbidity associated with TBI is now 
correlated with progressive degeneration attributed to diffuse damage in the brain, identification 
of relevant biological signaling pathways is critical for therapeutic intervention.  While a few 
secondary injury cascades associated with diffuse injury such as DAI have been identified, there 
remain few treatment strategies and no approved pharmacological agents to mitigate this 
damage.  Although potential treatment options such as membrane resealing agents like 
Poloxamer 188 have shown promising results in animal studies, experimental evidence suggests 
this may not be the only mechanism leading to diffuse damage.  A search of all current and 
previous NIH clinical studies (performed on 9/25/13 at clinicaltrials.gov) revealed only 10 
candidate therapeutics for mTBI, none of which directly target a mechanotransduction 
mechanism.  On the other hand, many therapeutic options currently exist that target cellular 
mechanotransduction pathways.  It is our intent that by applying the current knowledge and 
principles of cellular mechanotransduction to TBI, future studies may elucidate underlying 
mechanisms and therapeutic strategies previously unexplored in the context of TBI.      
5.2 Limitations of Current Studies and Suggested Future Directions 
Herein we have focused on implicating cell-ECM adhesions and their potential to localize 
forces to mechanosensitive FAs that mediate axonal injury.   As we believe this represents a 
critical advancement in understanding the mechanisms underlying TBI, we also acknowledge 
that many of our conclusions rely on previous work to connect the dots.  Furthermore, much of 
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the previous work relied on was not conducted in neurons nor verified in the adult central 
nervous system.  While the results reported previously have broad implications, several key 
limitations must also be addressed. 
The initial high speed stretcher studies were intended to minimize deviation from prior in 
vitro TBI studies while incorporating only a small change to study the effect of FAs.  In doing 
so, potential changes due to culturing of neurons on different ECM could not be controlled.  
While we reported clear differences in FA coverage due to culturing on either Poly-L-Lysine 
(PLL) or Fibronectin (FN) surfaces, we did not account for potential changes in gene expression 
or cytoskeleton organization that could also depend upon ECM composition.  While it is 
impossible to control for all biological variation, the particular importance of a consistent culture 
substrate was a primary motivation for moving to the MTC injury model in which all neurons are 
cultures similarly prior to injury experiments. Moreover, the global strain induced by substrate 
stretch is insufficient to localize forces through FAs.  We did establish a direct link between 
adhesion strength and vinculin density (data published in [126]), yet we cannot control for non-
specific interactions between cell membrane bound structures and the substrate.  Furthermore, 
multiple mechanisms exist by which mechanical forces are transduced within the cell [185], and, 
while we have focused on FAs, it is possible that cytoskeleton prestress or changes in the force 
balance between the cytoskeleton and the ECM post stretch could also provide potential 
mechanosensitive responses.   Therefore, the high speed stretcher experiments provided minimal 
deviation from established models of TBI, yet presented limitations to isolating the effects of 
cell-ECM adhesions.   
In order to minimize the influence of culture conditions and global strain, we sought to 
adapt MTC to use as an in vitro model of axonal injury.  Moving to this mode of mechanical 
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stimulus presented several important limitations as it represented a clear deviation from 
previously established models of axonal injury and most importantly a clear link between the 
magnitude of mechanical insult.  Whereas strain magnitude and rate were relatively easy to 
measure in the high speed stretcher experiments, measuring the exact mechanical stimulus 
produced by the MTC injury model presented many challenges.  Although this technique has 
been previously used to measure mechanical properties of cellular structures, individual 
measurements are typically acquired by averaging multiple cycles of bead twisting with highly 
sophisticated magnetometer setups and noise minimization techniques [294].  Incorporating 
these strategies to measure the mechanical stimulus provided by a single bead twist was deemed 
beyond the scope of this study as both a magnitude and rate dependency of mechanical stimuli 
has been previously reported in axonal injury studies.  Nonetheless, approximate magnitudes 
were provided and the potential for future studies to focus on specific force responses using this 
model is possible.     
Although we have provided a detailed description of the known brain ECM content and 
organization from the literature as well as additional immunostaining of both tissue sections and 
cell culture, it is clear that a comprehensive understanding is far from complete.  Numerous 
classes and sub-types of ECM molecules have been reported to exist in the brain and even an 
organized structure is beginning to emerge.  A key question remains in elucidating the specific 
ECM content and respective CAM binding that exists in axons, and moreover how this may 
differ in myelinated and non-myelinated axons.  Therefore, while we have identified specific 
ECM that may result in elevated sensitivity to mechanical forces, additional information about 
where this ECM occurs within the brain is necessary to determine if it can fully account for the 
regional susceptibility and multi-focal patterns observed in DAI [34].  In vivo studies are also 
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likely necessary to account for other differences in cellular microenvironment that were not 
considered here such as soluble factors or multicellular architecture. 
Finally, we presented evidence that brain ECM may direct forces through integrins and 
that this may be sufficient to induce axonal injury.  Integrins are the best studied class of CAMs 
and have been widely implicated in mechanosensitive pathways in multiple cell types [133,299] 
and were therefore the logical choice with which to begin.  By implicating integrins, we by no 
means suggest they are solely responsible for distributing forces that are injurious to neurons, but 
instead suggest they may represent a predominant conduit for force transmission, especially in 
the case of mild insults, that may provide a means by which neurons can actively respond to the 
mechanical insult.  From our current results, we cannot rule out additional mechanotransduction 
events, and in fact, suggest that TBI likely causes cellular damage through multiple mechanisms.  
While the evidence reported herein represents only the initial studies necessary to determine if 
mechanochemical coupling at the FA causes axonal injury, we believe that it is a promising 
target for future studies and should provide a foundation for future research. 
Both experimental design and interpretation of our findings have relied heavily on 
previous studies in the field of mechanotransduction.  Most of these studies have been performed 
on non-neuronal cells and those that are performed on neurons tend to focus on the developing 
nervous system.  Even so, there is strong evidence that propagation and distribution of forces 
through the cytoskeleton is a ubiquitous phenomenon that can initiate mechanotransduction 
signaling cascades, modulate cytoskeleton remodeling, and even alter ion channel activity 
without inducing membrane poration [70,208,299].  Interestingly, cytoskeleton remodeling has 
been shown to occur through integrin mediated activation of Rho signaling proteins that 
influence microtubule stability and actin dynamics [222,141], providing a potential link to the 
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microtubule breakdown and transport disruption observed in axonal injury. Given the existing 
evidence that supports the importance of mechanical forces directed through cell-ECM 
adhesions, future studies aimed at linking integrin mediated cellular mechanotransduction and 
previously reported secondary injury processes in axonal injury are warranted.  These include 
signaling pathways that regulate cytoskeleton structure and stability such as the class of integrin 
associated small GTPases including Rho, Rac, and CDC42.  We reported a successful decrease 
in axonal injury using the Rho-Associated Kinase (ROCK) inhibitor HA-1077.  ROCK is a 
downstream effector of Rho and is therefore to our knowledge the first implication of targeting 
integrin signaling for neuroprotection.  While these signaling pathways have been widely studied 
in non-neuronal cells, future studies will be necessary to determine the effectiveness of targeting 
pathways to treat TBI.   
The diverse content that comprises the brain ECM has the potential to interact with 
numerous CAMs.  While we have focused on integrins and integrin signaling as they are 
currently the best understood mechanosensors, additional membrane receptors including HAS, 
CD44, RHAMM, Layilin, and GPI-linked Brevican may also provide conduits into the neuron as 
they bind directly to HA and may thus serve as a physical link to the brain ECM [97].  Although 
we found that microbeads coated with HA elicited low injury levels, reports have shown that 
GPI-linked proteins interact with HA and can transmit extracellular forces to the cytoskeleton 
[297].  Therefore, while microbeads presented an effective means of controlling the local ECM 
content, they may not fully recapitulate the native form and extent of adhesion interactions 
between the neuron and its microenvironment.  Furthermore, in addition to the traditional cell-
ECM linkages that we have focused on, numerous cell-cell linkages also exist and support 
structural integrity.  Therefore, the existence of brain specific CAMs may provide additional 
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diversity that influences both the mechanical linkages and mechanochemical coupling that 
occurs in neurons.  
Future studies designed to elucidate the brain specific structures involved in cellular 
mechanotransduction as well as their associated signaling pathways will improve our ability to 
understand how the brain responds to exogenous mechanical forces, such as those experienced 
during TBI.  Key aspects to consider include: (1) Identifying the sub-cellular components 
involved in mechanotransduction within the brain, such as localized ECM and associated CAM 
expression and binding; (2) Understanding whether heterogeneities in the distribution of 
mechanosensitive cellular components can explain regional vulnerabilities to TBI; (3) 
Understanding if these mechanosensitive components can result in activation of signaling 
pathways that ultimately lead to the secondary injuries associated with TBI.   
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